Pre-existing treatment with aspirin or statins influences clinical presentation, infarct size and inflammation in patients with de novo acute coronary syndromes.
Weidmann L, Obeid S, Mach F, Shahin M, Yousif N, Denegri A, Muller O, Räber L, Matter CM, Lüscher TF.
Int J Cardiol. 2019;275:171-178.

Gender and age differences in outcomes of patients with acute coronary syndromes referred for coronary angiography.
Stähli BE, Wischnewsky MB, Jakob P, Klingenberg R, Obeid S, Heg D, Räber L, Windecker S, Mach F, Gencer B, Nanchen D, Jüni P, Landmesser U, Matter CM, Lüscher TF, Maier W.
Catheter Cardiovasc Interv. 2019;93:16-24.

Costantino S, Paneni F, Virdis A, Hussain S, Mohammed SA, Capretti G, Akhmedov A, Dalgaard K, Chiandotto S, Pospisilik JA, Jenuwein T, Giorgio M, Volpe M, Taddei S, Lüscher TF, Cosentino F.
Interplay among H3K9-editing enzymes SUV39H1, JMJD2C and SRC-1 drives p66Shc transcription and vascular oxidative stress in obesity.
Eur Heart J. 2019; 40:383-391.

Reiner MF, Müller D, Gobbato S, Stalder O, Limacher A, Bonetti NR, Pasterk L, Méan M, Rodondi N, Aujesky D, Angelillo-Scherrer A, Matter CM, Lüscher TF, Camici GG, von Eckardstein A, Beer JH.
Gut microbiota-dependent trimethylamine-N-oxide (TMAO) Shows a U-shaped Association With Mortality But Not With Recurrent Venous Thromboembolism.
Thromb Res 2019;174:40-47.

Increased Expression of miR-483-3p Impairs the Vascular Response to Injury in Type 2 Diabetes.
Kuschnerus K, Straessler ET, Müller MF, Lüscher TF, Landmesser U, Kränkel N.
Diabetes. 2019;68(2):349-360.

Diaz-Cañestro C, Reiner MF, Bonetti NR, Liberale L, Merlini M, Wüst P, Amstalden H, Briand-Schumacher S, Semerano A, Giacalone G, Sessa M, Beer JH, Akhmedov A, Lüscher TF, Camici GG.
AP-1 (Activated Protein-1) Transcription Factor JunD Regulates Ischemia/Reperfusion Brain Damage via IL (Interleukin)-1β.
Stroke. 2019 Jan 10 online.

Costantino S, Akhmedov A, Melina G, Mohammed SA, Othman A, Ambrosini S, Wijnen WJ, Sada L, Ciavarella GM, Liberale L, Tanner FC, Matter CM, Hornemann T, Volpe M, Mechta-Grigoriou F, Camici GG, Sinatra R, Lüscher TF, Paneni F.
Obesity-induced activation of JunD promotes myocardial lipid accumulation and metabolic cardiomyopathy.
Eur Heart J. 2019. DOI:10.1093/eurheartj/ehy903

Changes in Coronary Plaque Composition in Patients With Acute Myocardial Infarction Treated With High-Intensity Statin Therapy (IBIS-4): A Serial Optical Coherence Tomography Study.
Räber L, Koskinas KC, Yamaji K, Taniwaki M, Roffi M, Holmvang L, Garcia Garcia HM, Zanchin T, Maldonado R, Moschovitis A, Pedrazzini G, Zaugg S, Dijkstra J, Matter CM, Serruys PW, Lüscher TF, Kelbaek H, Karagiannis A, Radu MD, Windecker S.
JACC Cardiovasc Imaging. 2018; S1936-878X(18):30752-6.

Gut microbiota-dependent trimethylamine-N-oxide (TMAO) shows a U-shaped association with mortality but not with recurrent venous thromboembolism.
Reiner MF, Müller D, Gobbato S, Stalder O, Limacher A, Bonetti NR, Pasterk L, Méan M, Rodondi N, Aujesky D, Angelillo-Scherrer A, Matter CM, Lüscher TF, Camici GG, von Eckardstein A, Beer JH.
Thromb Res. 2018;174:40-47.

Prognostic Value of SYNTAX Score II in Patients with Acute Coronary Syndromes Referred for Invasive Management: A Subanalysis from the SPUM and COMFORTABLE AMI Cohorts.
Obeid S, Frangieh AH, Räber L, Yousif N, Gilhofer T, Yamaji K, Jaguszewski M, Aghlmandi S, Adams J, Bockhorn Y, Templin C, Stähli BE, Jüni P, Rodondi N, Mach F, Roffi M, Windecker S, Maier W, Nietlispach F, Matter CM, Klingenberg R, Lüscher TF.
Cardiol Res Pract. 2018;9762176.

Gender differences in types, frequency, clinical manifestations and atherosclerotic burden of coronary artery anomalies.
Yousif N, Shahin M, Luscher TF, Obeid S.
Rev Recent Clin Trials. 2018 Aug 19.

Coronary computed tomography angiography for heart team decision-making in multivessel coronary artery disease.
Collet C, Onuma Y, Andreini D, Sonck J, Pompilio G, Mushtaq S, La Meir M, Miyazaki Y, de Mey J, Gaemperli O, Ouda A, Maureira JP, Mandry D, Camenzind E, Macron L, Doenst T, Teichgräber U, Sigusch H, Asano T, Katagiri Y, Morel MA, Lindeboom W, Pontone G, Lüscher TF, Bartorelli AL, Serruys PW.
Eur Heart J. 2018;39:3689-3698.

Long-Term Prognosis of Patients With Takotsubo Syndrome.
Ghadri JR, Kato K, Cammann VL, Gili S, Jurisic S, Di Vece D, Candreva A, Ding KJ, Micek J, Szawan KA, Bacchi B, Bianchi R, Levinson RA, Wischnewsky M, Seifert B, Schlossbauer SA, Citro R, Bossone E, Münzel T, Knorr M, Heiner S, D'Ascenzo F, Franke J, Sarcon A, Napp LC, Jaguszewski M, Noutsias M, Katus HA, Burgdorf C, Schunkert H, Thiele H, Bauersachs J, Tschöpe C, Pieske BM, Rajan L, Michels G, Pfister R, Cuneo A, Jacobshagen C, Hasenfuß G, Karakas M, Koenig W, Rottbauer W, Said SM, Braun-Dullaeus RC, Banning A, Cuculi F, Kobza R, Fischer TA, Vasankari T, Airaksinen KEJ, Opolski G, Dworakowski R, MacCarthy P, Kaiser C, Osswald S, Galiuto L, Crea F, Dichtl W, Empen K, Felix SB, Delmas C, Lairez O, El-Battrawy I, Akin I, Borggrefe M, Horowitz J, Kozel M, Tousek P, Widimský P, Gilyarova E, Shilova A, Gilyarov M, Winchester DE, Ukena C, Bax JJ, Prasad A, Böhm M, Lüscher TF, Ruschitzka F, Templin C.
J Am Coll Cardiol. 2018;72:874-882.

Impact of gender on outcomes after transcatheter aortic valve implantation.
Yousif N, Obeid S, Binder R, Denegri A, Shahin M, Templin C, Lüscher TF.
J Geriatr Cardiol. 2018;15:394-400.

Deleterious role of endothelial lectin-like oxidized low-density lipoprotein receptor-1 in ischaemia/reperfusion cerebral injury.
Akhmedov A, Bonetti NR, Reiner MF, Spescha RD, Amstalden H, Merlini M, Gaul DS, Diaz-Cañestro C, Spescha RS, Semerano A, Giacalone G, Savarese G, Montecucco F, Kulic L, Nitsch RM, Matter CM, Kullak-Ublick GA, Sessa M, Lüscher TF, Beer JH, Liberale L, Camici GG.
J Cereb Blood Flow Metab. 2018:271678X18793266.

Hyperglycaemia-induced epigenetic changes drive persistent cardiac dysfunction via the adaptor p66Shc.
Costantino S, Paneni F, Mitchell K, Mohammed SA, Hussain S, Gkolfos C, Berrino L, Volpe M, Schwarzwald C, Lüscher TF, Cosentino F.
Int J Cardiol. 2018;268:179-186.

Prognostic value of pulse pressure after an acute coronary syndrome.
Harbaoui B, Nanchen D, Lantelme P, Gencer B, Heg D, Klingenberg R, Räber L, Carballo D, Matter CM, Windecker S, Mach F, Rodondi N, Eeckhout E, Monney P, Antiochos P, Schwitter J, Pascale P, Fournier S, Courand PY, Lüscher TF, Muller O.
Atherosclerosis. 2018;277:219-226. 

Hybrid SPECT Perfusion Imaging and Coronary CT Angiography: Long-term Prognostic Value for Cardiovascular Outcomes.
Pazhenkottil AP, Benz DC, Gräni C, Madsen MA, Mikulicic F, von Felten E, Fuchs TA, Moch BH, Stehli J, Lüscher TF, Gaemperli O, Buechel RR, Kaufmann PA.
Radiology. 2018;288:694-702.

Approximation of the Incidence of Myocarditis by Systematic Screening With Cardiac Magnetic Resonance Imaging.
Patriki D, Gresser E, Manka R, Emmert MY, Lüscher TF, Heidecker B.
JACC Heart Fail. 2018;6:573-579.

Predictive value of the age, creatinine, and ejection fraction (ACEF) score in patients with acute coronary syndromes.
Stähli BE, Wischnewsky MB, Jakob P, Klingenberg R, Obeid S, Heg D, Räber L, Windecker S, Roffi M, Mach F, Gencer B, Nanchen D, Jüni P, Landmesser U, Matter CM, Lüscher TF, Maier W.
Int J Cardiol. 2018;270:7-13.

Prognostic values of fasting hyperglycaemia in non-diabetic patients with acute coronary syndrome: A prospective cohort study.
Gencer B, Rigamonti F, Nanchen D, Klingenberg R, Räber L, Moutzouri E, Auer R, Carballo D, Heg D, Windecker S, Lüscher TF, Matter CM, Rodondi N, Mach F, Roffi M.
Eur Heart J Acute Cardiovasc Care. 2018:2048872618777819.

The effect of oxygen in Sirt3-mediated myocardial protection: a proof-of-concept study in cultured cardiomyoblasts.
Diehl P, Gaul DS, Sogl J, Flierl U, Henstridge D, Pahla J, Bugger H, Emmert MY, Ruschitzka F, Bode C, Lüscher TF, Moser M, Matter CM, Peter K, Winnik S.
J Thromb Thrombolysis. 2018;46:102-112.

Long-term durability and haemodynamic performance of a self-expanding transcatheter heart valve beyond five years after implantation: a prospective observational study applying the standardised definitions of structural deterioration and valve failure.
Holy EW, Kebernik J, Abdelghani M, Stämpfli SF, Hellermann J, Allali A, El-Mawardy M, Sachse S, Lüscher TF, Tanner FC, Richardt G, Abdel-Wahab M.
EuroIntervention. 2018;14:e390-e396.

Effect of Aspirin Coadministration on the Safety of Celecoxib, Naproxen, or Ibuprofen.
Reed GW, Abdallah MS, Shao M, Wolski K, Wisniewski L, Yeomans N, Lüscher TF, Borer JS, Graham DY, Husni ME, Solomon DH, Libby P, Menon V, Lincoff AM, Nissen SE.
J Am Coll Cardiol. 2018;71:1741-1751.

Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial.
Yeomans ND, Graham DY, Husni ME, Solomon DH, Stevens T, Vargo J, Wang Q, Wisniewski LM, Wolski KE, Borer JS, Libby P, Lincoff AM, Lüscher TF, Bao W, Walker C, Nissen SE.
Aliment Pharmacol Ther. 2018;47:1453-1463.

Incidence, Predictors, and Clinical Impact of Early Prasugrel Cessation in Patients With ST-Elevation Myocardial Infarction.
Koskinas KC, Zanchin T, Klingenberg R, Gencer B, Temperli F, Baumbach A, Roffi M, Moschovitis A, Muller O, Tüller D, Stortecky S, Mach F, Lüscher TF, Matter CM, Pilgrim T, Heg D, Windecker S, Räber L.
J Am Heart Assoc. 2018;7(8).

Renal artery anatomy assessed by quantitative analysis of selective renal angiography in 1,000 patients with hypertension.
Lauder L, Ewen S, Tzafriri AR, Edelman ER, Lüscher TF, Blankenstijn PJ, Dörr O, Schlaich M, Sharif F, Voskuil M, Zeller T, Ukena C, Scheller B, Böhm M, Mahfoud F; Renal artery anatomy in hypertensive patients study collaborators.
EuroIntervention. 2018;14:121-128.

Renal nerve ablation reduces blood pressure in resistant hypertension: Long-term clinical outcomes in a single-center experience.
Denegri A, Naduvathumuriyil T, Lüscher TF, Sudano I.
J Clin Hypertens. 2018;20:627-633.

Untargeted metabolomics identifies trimethyllysine, a TMAO-producing nutrient precursor, as a predictor of incident cardiovascular disease risk.
Li XS, Wang Z, Cajka T, Buffa JA, Nemet I, Hurd AG, Gu X, Skye SM, Roberts AB, Wu Y, Li L, Shahen CJ, Wagner MA, Hartiala JA, Kerby RL, Romano KA, Han Y, Obeid S, Lüscher TF, Allayee H, Rey FE, DiDonato JA, Fiehn O, Tang WHW, Hazen SL.
JCI Insight. 2018 Mar 22;3(6). pii: 99096.

Short-Term Outcome After Left Main Interventions in Patients Presenting With Acute Coronary Syndrome.
Obeid S, Yousif N, Schelldorfer A, Shahin M, Räber L, Gencer B, Mach F, Roffi M, Matter CM, Windecker S, Lüscher TF.
J Invasive Cardiol. 2018;30:98-104.

Non-invasive screening for coronary artery disease in asymptomatic diabetic patients: a systematic review and meta-analysis of randomised controlled trials.
Clerc OF, Fuchs TA, Stehli J, Benz DC, Gräni C, Messerli M, Giannopoulos AA, Buechel RR, Lüscher TF, Pazhenkottil AP, Kaufmann PA, Gaemperli O.
Eur Heart J Cardiovasc Imaging. 2018;19:838-846.

Takotsubo Syndrome Associated With Structural Brain Alterations of the Limbic System.
Hiestand T, Hänggi J, Klein C, Topka MS, Jaguszewski M, Ghadri JR, Lüscher TF, Jäncke L, Templin C.
J Am Coll Cardiol. 2018;71:809-811.

Loss of Sirt3 accelerates arterial thrombosis by increasing formation of neutrophil extracellular traps and plasma tissue factor activity.
Gaul DS, Weber J, van Tits LJ, Sluka S, Pasterk L, Reiner MF, Calatayud N, Lohmann C, Klingenberg R, Pahla J, Vdovenko D, Tanner FC, Camici GG, Eriksson U, Auwerx J, Mach F, Windecker S, Rodondi N, Lüscher TF, Winnik S, Matter CM.
Cardiovasc Res. 2018;114:1178-1188.

Differences in Safety of Nonsteroidal Antiinflammatory Drugs in Patients With Osteoarthritis and Patients With Rheumatoid Arthritis: A Randomized Clinical Trial.
Solomon DH, Husni ME, Wolski KE, Wisniewski LM, Borer JS, Graham DY, Libby P, Lincoff AM, Lüscher TF, Menon V, Yeomans ND, Wang Q, Bao W, Berger MF, Nissen SE; PRECISION Trial Investigators.
Arthritis Rheumatol. 2018;70(4):537-546.

Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis.
Anker SD, Kirwan BA, van Veldhuisen DJ, Filippatos G, Comin-Colet J, Ruschitzka F, Lüscher TF, Arutyunov GP, Motro M, Mori C, Roubert B, Pocock SJ, Ponikowski P.
Eur J Heart Fail. 2018;20:125-133.

Thrombus aspiration in acute coronary syndromes: prevalence, procedural success, change in serial troponin T levels and clinical outcomes in a contemporary Swiss cohort.
Aghlmandi S, Schärer N, Heg D, Räber L, Zwahlen M, Gencer B, Nanchen D, Carballo D, Carballo S, Jüni P, von Eckardstein A, Landmesser U, Rodondi N, Mach F, Windecker S, Matter CM, Lüscher TF, Klingenberg R.
Eur Heart J Acute Cardiovasc Care. 2018;7:522-531.

Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE score.
Klingenberg R, Aghlmandi S, Räber L, Gencer B, Nanchen D, Heg D, Carballo S, Rodondi N, Mach F, Windecker S, Jüni P, von Eckardstein A, Matter CM, Lüscher TF.
Eur Heart J Acute Cardiovasc Care. 2018;7:129-138.

Akhmedov A, Bonetti NR, Reiner MF, Spescha RD, Amstalden H, Merlini M, Gaul DS, Diaz-Cañestro C, Spescha RS, Semerano A, Giacalone G, Savarese G, Montecucco F, Kulic L, Nitsch RM, Matter CM, Kullak-Ublick GA, Sessa M, Lüscher TF, Beer JH, Liberale L, Camici GG.
Deleterious role of endothelial lectin-like oxidized low-density lipoprotein receptor-1 in ischaemia/reperfusion cerebral injury.
J Cereb Blood Flow Metab. 2018 Aug 3 online.

Liberale L, Diaz-Cañestro C, Bonetti NR, Paneni F, Akhmedov A, Beer JH, Montecucco F, Lüscher TF, Camici GG.
Post-ischemic administration of the murine Canakinumab-surrogate antibody improves outcome in experimental stroke.
Eur Heart J. 2018;39(38):3511-3517.

Diaz-Cañestro C, Merlini M, Bonetti NR, Liberale L, Wüst P, Briand-Schumacher S, Klohs J, Costantino S, Miranda M, Schoedon-Geiser G, Kullak-Ublick GA, Akhmedov A, Paneni F, Beer JH, Lüscher TF, Camici GG.
Sirtuin 5 as a novel target to blunt blood-brain barrier damage induced by cerebral ischemia/reperfusion injury.
Int J Cardiol. 2018;260:148-155.

Filipovic MG, Aeschbacher S, Reiner MF, Stivala S, Gobbato S, Bonetti N, Risch M, Risch L, Camici GG, Luescher TF, von Schacky C, Conen D, Beer JH.
Whole blood omega-3 fatty acid concentrations are inversely associated with blood pressure in young, healthy adults.
J Hypertens. 2018;36(7):1548-1554.

Costantino S, Paneni F, Mitchell K, Mohammed SA, Hussain S, Gkolfos C, Berrino L, Volpe M, Schwarzwald C, Lüscher TF, Cosentino F.
Hyperglycaemia-induced epigenetic changes drive persistent cardiac dysfunction via the adaptor p66Shc.
Int J Cardiol. 2018;268:179-186.

Gaul DS, Weber J, Van Tits LJ, Sluka S, Pasterk L, Reiner MF, Calatayud N, Lohmann C, Klingenberg R, Pahla J, Vdovenko D, Tanner FC, Camici GG, Eriksson U, Auwerx J, Mach F, Windecker S, Rodondi N, Lüscher TF, Winnik S, Matter CM.
Loss of Sirt3 accelerates arterial thrombosis by increasing formation of neutrophil extracellular traps and plasma tissue factor activity.
Cardiovasc. Res. 2018;114(8):1178–1188.

Diehl P, Gaul DS, Sogl J, Flierl U, Henstridge D, Pahla J, Bugger H, Emmert MY, Ruschitzka F, Bode C, Lüscher TF, Moser M, Matter CM, Peter K, Winnik S.
The effect of oxygen in Sirt3-mediated myocardial protection: a proof-of-concept study in cultured cardiomyoblasts.
J Thromb Thrombolysis. 2018;46(1):102-112.

What is a normal blood pressure?
Lüscher TF.
Eur Heart J. 2018;39:2233-2240.  

International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology.
Ghadri JR, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ, Cammann VL, Crea F, Galiuto L, Desmet W, Yoshida T, Manfredini R, Eitel I, Kosuge M, Nef HM, Deshmukh A, Lerman A, Bossone E, Citro R, Ueyama T, Corrado D, Kurisu S, Ruschitzka F, Winchester D, Lyon AR, Omerovic E, Bax JJ, Meimoun P, Tarantini G, Rihal C, Y-Hassan S, Migliore F, Horowitz JD, Shimokawa H, Lüscher TF, Templin C.
Eur Heart J. 2018;39:2032-2046.

International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management.
Ghadri JR, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ, Cammann VL, Crea F, Galiuto L, Desmet W, Yoshida T, Manfredini R, Eitel I, Kosuge M, Nef HM, Deshmukh A, Lerman A, Bossone E, Citro R, Ueyama T, Corrado D, Kurisu S, Ruschitzka F, Winchester D, Lyon AR, Omerovic E, Bax JJ, Meimoun P, Tarantini G, Rihal C, Y-Hassan S, Migliore F, Horowitz JD, Shimokawa H, Lüscher TF, Templin C.
Eur Heart J. 2018;39:2047-2062.

Ischemic stroke across sexes: What is the status quo?
Liberale L, Carbone F, Montecucco F, Gebhard C, Lüscher TF, Wegener S, Camici GG.
Front Neuroendocrinol. 2018;50:3-17.

New prospects for PCSK9 inhibition?
Landmesser U, Chapman MJ, Stock JK, Amarenco P, Belch JJF, Borén J, Farnier M, Ference BA, Gielen S, Graham I, Grobbee DE, Hovingh GK, Lüscher TF, Piepoli MF, Ray KK, Stroes ES, Wiklund O, Windecker S, Zamorano JL, Pinto F, Tokgözoglu L, Bax JJ, Catapano AL; European Society of Cardiology/European Atherosclerosis Society Task Force.
Eur Heart J. 2018;39:2600-2601.

Global Overview of the Transnational Alliance for Regenerative Therapies in Cardiovascular Syndromes (TACTICS) Recommendations: A Comprehensive Series of Challenges and Priorities of Cardiovascular Regenerative Medicine.
Fernández-Avilés F, Sanz-Ruiz R, Climent AM, Badimon L, Bolli R, Charron D, Fuster V, Janssens S, Kastrup J, Kim HS, Lüscher TF, Martin JF, Menasché P, Pinto FJ, Simari RD, Stone GW, Terzic A, Willerson JT, Wu JC; TACTICS Writing Group.
Circ Res. 2018;122:199-201.

2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia.
Landmesser U, Chapman MJ, Stock JK, Amarenco P, Belch JJF, Borén J, Farnier M, Ference BA, Gielen S, Graham I, Grobbee DE, Hovingh GK, Lüscher TF, Piepoli MF, Ray KK, Stroes ES, Wiklund O, Windecker S, Zamorano JL, Pinto F, Tokgözoglu L, Bax JJ, Catapano AL.
Eur Heart J. 2018;39:1131-1143.

Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins: an analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration.
Ference BA, Cannon CP, Landmesser U, Lüscher TF, Catapano AL, Ray KK.
Eur Heart J. 2018;39:2540-2545.

Epigenetics and cardiovascular regenerative medicine in the elderly.
Costantino S, Camici GG, Mohammed SA, Volpe M, Lüscher TF, Paneni F.
Int J Cardiol. 2018;250:207-214.

Liberale L, Carbone F, Montecucco F, Gebhard C, Lüscher TF, Wegener S, Camici GG
Drug development for brain disorders: Why sex matters: Ischemic stroke across sexes: what is the status quo?
Front Neuroendocrinol. 2018;50:3-17.

The future of scientific publishing
Lüscher TF.
EuroIntervention 2019; in press

Misconceptions and Facts About Takotsubo Syndrome.
Rodríguez M, Rzechorzek W, Herzog E, Lüscher TF.
Am J Med. 2019;132:25-31.

The red and the white, and the difference it makes.
Davies A., Lüscher TF.
Eur Heart J. 2019 Jan 11. doi: 10.1093/eurheartj/ehy905. [Epub ahead of print]

Has the time finally come to measure hsCRP universally in primary and secondary cardiovascular prevention?
Ridker PM, Koenig W, Kastelein JJ, Mach F, Lüscher TF.
Eur Heart J. 2018;39:4109-4111.

CANTOS: a seductive song with several verses.
Klingenberg R, Lüscher TF.
Eur Heart J. 2018;39:3508-3510.

The 2018 ESC-ESH guidelines for the management of arterial hypertension leave clinicians facing a dilemma in half of the patients.
Vidal-Petiot E, Elbez Y, Lüscher TF, Fox KM, Steg PG.
Eur Heart J. 2018;39:4040-4041.

Will SPYRAL HTN-ON MED change my practice? SPYRAL HTN-ON MED: a prospective, randomised, sham-controlled trial on renal denervation in the presence of antihypertensive medications.
Ewen S, Lauder L, Azizi M, Kandzari DE, Pathak A, Sharif F, Wijns W, Mahfoud F, Lüscher TF.
EuroIntervention. 2018;14:e598-e602.

Takotsubo syndrome: the Cinderella compared with common acute coronary syndromes.
Lüscher TF.
Eur Heart J. 2018;39:2017-2020.

Measuring the unmeasurable: assessing the quality of science and scientists.
Lüscher TF.
Eur Heart J. 2018;39:1765-1769.

ORBITA revisited: what it really means and what it does not?
Chaitman BR, Mori Brooks M, Fox K, Lüscher TF.
Eur Heart J. 2018;39:963-965.

The circadian clock in cardiovascular regulation and disease: Lessons from the Nobel Prize in Physiology or Medicine 2017.
Van Laake LW, Lüscher TF, Young ME.
Eur Heart J. 2018;39:2326-2329.

Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.
Li XS, Obeid S, Klingenberg R, Gencer B, Mach F, Räber L, Windecker S, Rodondi N, Nanchen D, Muller O, Miranda MX, Matter CM, Wu Y, Li L, Wang Z, Alamri HS, Gogonea V, Chung YM, Tang WH, Hazen SL, Lüscher TF.
Eur Heart J. 2017;14;38(11):814-24.

Impaired SUMOylation of nuclear receptor LRH-1 promotes nonalcoholic fatty liver disease.
Stein S, Lemos V, Xu P, Demagny H, Wang X, Ryu D, Jimenez V, Bosch F, Lüscher TF, Oosterveer MH, Schoonjans K.
J Clin Invest. 2017; 127(2):583-92.

Omega-3 fatty acids predict recurrent venous thromboembolism or total mortality in elderly patients with acute venous thromboembolism.
Reiner MF, Stivala S, Limacher A, Bonetti NR, Méan M, Egloff M, Rodondi N, Aujesky D, von Schacky C, Lüscher TF, Camici GG, Beer JH.
J Thromb Haemost. 2017;15(1):47-56.

Reduced nitric oxide bioavailability mediates cerebroarterial dysfunction independent of cerebral amyloid angiopathy in a mouse model of Alzheimer's disease.
Merlini M, Shi Y, Keller S, Savarese G, Akhmedov A, Derungs R, Spescha RD, Kulic L, Nitsch RM, Lüscher TF, Camici GG.
Am J Physiol Heart Circ Physiol. 2017;1;312(2):H232-8.

Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.
Nissen SE, Yeomans ND, Solomon DH, Lüscher TF, Libby P, Husni ME, Graham DY, Borer JS, Wisniewski LM, Wolski KE, Wang Q, Menon V, Ruschitzka F, Gaffney M, Beckerman B, Berger MF, Bao W, Lincoff AM; PRECISION Trial Investigators.
N Engl J Med. 2016;375(26):2519-29.

Carbamylated Low-Density Lipoproteins Induce a Prothrombotic State Via LOX-1: Impact on Arterial Thrombus Formation In Vivo.
Holy EW, Akhmedov A, Speer T, Camici GG, Zewinger S, Bonetti N, Beer JH, Lüscher TF, Tanner FC.
J Am Coll Cardiol. 2016 ;68(15):1664-76.

Increased proangiogenic activity of mobilized CD34+ progenitor cells of patients with acute ST-segment-elevation myocardial infarction: role of differential micro-RNA-378 expression.
Templin C, Volkmann J, Emmert MY, Mocharla P, Müller M, Kraenkel N, Ghadri JR, Meyer M, Styp-Rekowska B, Briand S, Klingenberg R, Jaguszewski M, Matter CM, Djonov V, Mach F, Windecker S, Hoerstrup SP, Thum T, Lüscher TF, Landmesser U.
Arterioscler Thromb Vasc Biol 2017;37(2):341-9.

Uptake and efficacy of a systematic intensive smoking cessation intervention using motivational interviewing for smokers hospitalised for an acute coronary syndrome: a multicentre before-after study with parallel group comparisons.
Auer R, Gencer B, Tango R, Nanchen D, Matter CM, Lüscher TF, Windecker S, Mach F, Cornuz J, Humair JP, Rodondi N.
BMJ Open. 2016;6(9):e011520.

Impact of postdilatation on performance of bioresorbable vascular scaffolds in patients with acute coronary syndrome compared with everolimus-eluting stents: A propensity score-matched analysis from a multicenter "real-world" registry.
Imori Y, D'Ascenzo F, Gori T, Münzel T, Fabrizio U, Campo G, Cerrato E, Napp LC, Iannaccone M, Ghadri JR, Kazemian E, Binder RK, Jaguszewski M, Csordas A, Capasso P, Biscaglia S, Conrotto F, Varbella F, Garbo R, Gaita F, Erne P, Lüscher TF, Moretti C, Frangieh AH, Templin C.
Cardiol J. 2016;23(4):374-83.

Changes in serum biomarker profiles after percutaneous mitral valve repair with the MitraClip system.
Yoon JN, Frangieh AH, Attinger-Toller A, Gruner C, Tanner FC, Taramasso M, Corti R, Lüscher TF, Ruschitzka F, Bettex D, Maisano F, Gaemperli O.
Cardiol J. 2016;23(4):384-92.

Ticagrelor, but not clopidogrel, reduces arterial thrombosis via endothelial tissue factor suppression.
Reiner MF, Akhmedov A, Stivala S, Keller S, Gaul DS, Bonetti NR, Savarese G, Glanzmann M, Zhu C, Ruf W, Yang Z, Matter CM, Lüscher TF, Camici GG, Beer JH.
Cardiovasc Res. 2017;113(1):61-9.

Impact of an optical coherence tomography guided approach in acute coronary syndromes: A propensity matched analysis from the international FORMIDABLE-CARDIOGROUP IV and USZ registry.
Iannaccone M, D'Ascenzo F, Frangieh AH, Niccoli G, Ugo F, Boccuzzi G, Bertaina M, Mancone M, Montefusco A, Amabile N, Sardella G, Motreff P, Toutouzas K, Colombo F, Garbo R, Biondi-Zoccai G, Tamburino C, Omedè P, Moretti C, D'amico M, Souteyrand G, Meieir P, Lüscher TF, Gaita F, Templin C.
Catheter Cardiovasc Interv. 2016;Dec 28. [Epub ahead of print]

Efficacy and safety of prolonged dual antiplatelet therapy: a meta-analysis of 15 randomized trials enrolling 85 265 patients
Savarese G, Savonitto S, Lund LH, Paolillo S, Marciano C, Dellegrottaglie S, Parente A, Trimarco B, Luscher TF, Perrone-Filardi P.
Eur Heart J Cardiovasc Pharmacother. 2016;2(4):218-28.

P2Y12 receptor inhibitors in patients with non-ST-elevation acute coronary syndrome in the real world: use, patient selection, and outcomes from contemporary European registries.
Zeymer U, Widimsky P, Danchin N, Lettino M, Bardaji A, Barrabes JA, Cequier A, Claeys MJ, De Luca L, Dörler J, Erlinge D, Erne P, Goldstein P, Koul SM, Lemesle G, Lüscher TF, Matter CM, Montalescot G, Radovanovic D, Sendón JL, Tousek P, Weidinger F, Weston CF, Zaman A, Andell P, Li J, Jukema JW; PIRAEUS group.
Eur Heart J Cardiovasc Pharmacother. 2016;2(4):229-43.

Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registries.
Danchin N, Lettino M, Zeymer U, Widimsky P, Bardaji A, Barrabes JA, Cequier A, Claeys MJ, De Luca L, Dörler J, Erlinge D, Erne P, Goldstein P, Koul SM, Lemesle G, Lüscher TF, Matter CM, Montalescot G, Radovanovic D, Lopez Sendón J, Tousek P, Weidinger F, Weston CF, Zaman A, Andell P, Li J, Jukema JW; PIRAEUS group.
Eur Heart J Cardiovasc Pharmacother. 2016;2(3):152-67.

A novel clinical score (InterTAK Diagnostic Score) to differentiate Takotsubo syndrome from acute coronary syndrome: results from the International Takotsubo Registry.
Ghadri JR, Cammann VL, Jurisic S, Seifert B, Napp LC, Diekmann J, Bataiosu DR, D'Ascenzo F, Ding KJ, Sarcon A, Kazemian E, Birri T, Ruschitzka F, Lüscher TF, Templin C; InterTAK co-investigators.
Eur J Heart Fail. 2016;2(3):152-67.

Pre-hospital alarm activation for STEMI patients undergoing primary percutaneous coronary intervention in the era of transradial procedures.
Rigamonti F, Gencer B, Rey F, Chaara J, Tessitore E, Bunwaree S, Meier P, Noble S, Grosgurin O, Larribau R, Windecker S, Carbone F, Montecucco F, Rodondi N, Matter CM, Luscher TF, Mach F, Roffi M.
Eur J Intern Med. 2016;35:83-8.

TCT-297 percutaneous coronary intervention of chronic total occlusions in patients with low left ventricular ejection fraction.
Galassi A, Boukhris M, Belhadj Z, Laaroussi L, Ghanem I, Tomasello D, Toma A, Gaemperli O, Luscher T, Mashayekhi K.
J Am Coll Cardiol. 2016;68(18S):B121-B122.

ECG criteria to differentiate between Takotsubo (stress) cardiomyopathy and myocardial infarction.
Frangieh AH, Obeid S, Ghadri JR, Imori Y, D'Ascenzo F, Kovac M, Ruschitzka F, Lüscher TF, Duru F, Templin C; InterTAK Collaborators.
J Am Heart Assoc. 2016;5(6):e003418.

The electrocardiogram after transcatheter aortic valve replacement determines the risk for post-procedural high-degree AV block and the need for telemetry monitoring.
Toggweiler S, Stortecky S, Holy E, Zuk K, Cuculi F, Nietlispach F, Sabti Z, Suciu R, Maier W, Jamshidi P, Maisano F, Windecker S, Kobza R, Wenaweser P, Lüscher TF, Binder RK.
JACC Cardiovasc Interv. 2016;9(12):1269-76.

"One-Stop Shop": safety of combining transcatheter aortic valve replacement and left atrial appendage occlusion.
Attinger-Toller A, Maisano F, Senn O, Taramasso M, Shakir S, Possner M, Gloekler S, Windecker S, Stortecky S, Lüscher TF, Meier B, Nietlispach F.
JACC Cardiovasc Interv. 2016;9(14):1487-95.

Health utility indexes in patients with acute coronary syndromes.
Gencer B, Rodondi N, Auer R, Nanchen D, Räber L, Klingenberg R, Pletscher M, Jüni P, Windecker S, Matter CM, Lüscher TF, Mach F, Perneger TV, Girardin FR.
Open Heart. 2016;3(1):e000419.

The MAP kinase JNK2 mediates cigarette smoke-induced arterial thrombosis.
Breitenstein A, Stämpfli SF, Reiner MF, Shi Y, Keller S, Akhmedov A, Schaub Clerigué A, Spescha RD, Beer HJ, Lüscher TF, Tanner FC, Camici GG.
Thromb Haemost. 2017;117(1):83-9.

Unfavorable donor pretransplant APACHE II, SAPS II, and SOFA Scores are not associated with outcome: implications for heart transplant donor selection.
Rizzi G, Startseva X, Wolfrum M, Lüscher TF, Ruschitzka F, Fröhlich GM, Enseleit F.
Transplant Proc. 2016;48(8):2582-7.

Differences in the clinical profile and outcomes of typical and atypical Takotsubo syndrome: data from the International Takotsubo Registry.
Ghadri JR, Cammann VL, Napp LC, Jurisic S, Diekmann J, Bataiosu DR, Seifert B, Jaguszewski M, Sarcon A, Neumann CA, Geyer V, Prasad A, Bax JJ, Ruschitzka F, Lüscher TF, Templin C; International Takotsubo (InterTAK) Registry.
JAMA Cardiol. 2016;1(3):335-40.

Relation of longitudinal changes in quality of life assessments to changes in functional capacity in patients with heart failure with and without anemia.
Cooper TJ, Anker SD, Comin-Colet J, Filippatos G, Lainscak M, Lüscher TF, Mori C, Johnson P, Ponikowski P, Dickstein K.
Am J Cardiol. 2016;117(9):1482-7.

Meta-analysis of the duration of dual antiplatelet therapy in patients treated with second-generation drug-eluting stents.
D'Ascenzo F, Moretti C, Bianco M, Bernardi A, Taha S, Cerrato E, Omedè P, Montefusco A, Frangieh AH, Lee CW, Campo G, Chieffo A, Quadri G, Pavani M, Zoccai GB, Gaita F, Park SJ, Colombo A, Templin C, Lüscher TF, Stone GW.
Am J Cardiol. 2016;117(11):1714-23.

Decreased phosphatidylcholine plasmalogens – a putative novel lipid signature in patients with stable coronary artery disease and acute myocardial infarction.
Sutter I, Klingenberg R, Othman A, Rohrer L, Landmesser U, Heg D, Rodondi N, Mach F, Windecker S, Matter CM, Lüscher TF, von Eckardstein A, Hornemann T.
Atherosclerosis. 2016;246:130-40.

Changes of coronary plaque composition correlate with C-reactive protein levels in patients with ST-elevation myocardial infarction following high-intensity statin therapy.
Koskinas KC, Zaugg S, Yamaji K, García-García HM, Taniwaki M, Klingenberg R, Moschovitis A, Lüscher TF, van Tits LJ, Matter CM, Windecker S, Räber L.
Atherosclerosis. 2016;247:154-60.

Mild endothelial dysfunction in Sirt3 knockout mice fed a high-cholesterol diet: protective role of a novel C/EBP-β-dependent feedback regulation of SOD2.
Winnik S, Gaul DS, Siciliani G, Lohmann C, Pasterk L, Calatayud N, Weber J, Eriksson U, Auwerx J, van Tits LJ, Lüscher TF, Matter CM.
Basic Res Cardiol. 2016;111(3):33.

Safety and efficacy profile of bioresorbable-polylactide-polymer-biolimus-A9-eluting stents versus durable-polymer-everolimus- and zotarolimus-eluting stents in patients with acute coronary syndrome.
Jaguszewski M, Dörig M, Frangieh AH, Ghadri JR, Cammann VL, Diekmann J, Napp LC, D'Ascenzo F, Imori Y, Obeid S, Maier W, Lüscher TF, Templin C.
Catheter Cardiovasc Interv. 2016. [Epub ahead of print]

Effect of Bone Marrow-Derived Mononuclear Cell Treatment, Early or Late After Acute Myocardial Infarction: Twelve Months CMR and Long-Term Clinical Results.
Sürder D, Manka R, Moccetti T, Lo Cicero V, Emmert MY, Klersy C, Soncin S, Turchetto L, Radrizzani M, Zuber M, Windecker S, Moschovitis A, Bühler I, Kozerke S, Erne P, Lüscher TF, Corti R.
Circ Res. 2016;119(3):481-90.

Prognosis of patients with familial hypercholesterolemia after acute coronary syndromes.
Nanchen D, Gencer B, Muller O, Auer R, Aghlmandi S, Heg D, Klingenberg R, Räber L, Carballo D, Carballo S, Matter CM, Lüscher TF, Windecker S, Mach F, Rodondi N.
Circulation. 2016;134(10):698-709.

Dual Antiplatelet Therapy and Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndromes Managed Medically Without Revascularization: Insights From the TRILOGY ACS Trial.
Jackson LR 2nd, Piccini JP, Cyr DD, Roe MT, Neely ML, Martinez F, Lüscher TF, Lopes RD, Winters KJ, White HD, Armstrong PW, Fox KA, Prabhakaran D, Bhatt DL, Magnus Ohman E, Corbalán R.
Clin Cardiol. 2016;39(9):497-506.

Vascular effects of eplerenone in coronary artery disease with preserved ejection fraction: a double-blind, randomized, placebo-controlled trial.
Sudano I, Naegele M, Roas S, Périat D, Frank M, Kouroedov A, Noll G, Lüscher TF, Enseleit F, Ruschitzka F, Flammer AJ.
Clin Cardiol. 2016;39(5):285-90.

Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol.
Laaksonen R, Ekroos K, Sysi-Aho M, Hilvo M, Vihervaara T, Kauhanen D, Suoniemi M, Hurme R, Marz W, Scharnagl H, Stojakovic T, Vlachopoulou E, Lokki M-L, Nieminen MS, Klingenberg R, Matter CM, Hornemann T, Jüni P, Rodondi N, Räber L, Windecker S, Gencer B, Ringdal Pedersen E, Tell GS, Nygård O, Mach F, Sinisalo J, Lüscher TF.
Eur Heart J. 2016;37(25):1967-76.

Prognostic value of PCSK9 levels in patients with acute coronary syndromes.
Gencer B, Montecucco F, Nanchen D, Carbone F, Klingenberg R, Vuilleumier N, Aghlmandi S, Heg D, Räber L, Auer R, Jüni P, Windecker S, Lüscher TF, Matter CM, Rodondi N, Mach F.
Eur Heart J. 2016;37:546–53.

MicroRNA profiling unveils hyperglycaemic memory in the diabetic heart.
Costantino S, Paneni F, Lüscher TF, Cosentino F.
Eur Heart J. 2016;37(6):572-6.

Association of left bundle branch block with obstructive coronary artery disease on coronary CT angiography: a case-control study.
Clerc OF, Possner M, Maire R, Liga R, Fuchs TA, Stehli J, Vontobel J, Mikulicic F, Gräni C, Benz DC, Lüscher TF, Herzog BA, Buechel RR, Kaufmann PA, Gaemperli O.
Eur Heart J Cardiovasc Imaging. 2016;17(7):765-71.

Clinical features and outcomes of Takotsubo (stress) cardiomyopathy.
Templin C, Ghadri JR, Diekmann J, Napp LC, Bataiosu DR, Jaguszewski M, Cammann VL, Sarcon A, Geyer V, Neumann CA, Seifert B, Hellermann J, Schwyzer M, Eisenhardt K, Jenewein J, Franke J, Katus HA, Burgdorf C, Schunkert H, Moeller C, Thiele H, Bauersachs J, Tschöpe C, Schultheiss HP, Laney CA, Rajan L, Michels G, Pfister R, Ukena C, Böhm M, Erbel R, Cuneo A, Kuck KH, Jacobshagen C, Hasenfuss G, Karakas M, Koenig W, Rottbauer W, Said SM, Braun-Dullaeus RC, Cuculi F, Banning A, Fischer TA, Vasankari T, Airaksinen KE, Fijalkowski M, Rynkiewicz A, Pawlak M, Opolski G, Dworakowski R, MacCarthy P, Kaiser C, Osswald S, Galiuto L, Crea F, Dichtl W, Franz WM, Empen K, Felix SB, Delmas C, Lairez O, Erne P, Bax JJ, Ford I, Ruschitzka F, Prasad A, Lüscher TF.
N Engl J Med. 2015;3;373(10):929-38.

Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes.
Nanchen D, Gencer B, Auer R, Räber L, Stefanini GG, Klingenberg R, Schmied CM, Cornuz J, Muller O, Vogt P, Jüni P, Matter CM, Windecker S, Lüscher TF, Mach F, Rodondi N.
Eur Heart J. 2015;21;36(36):2438-45.

Post-ischaemic silencing of p66Shc reduces ischaemia/reperfusion brain injury and its expression correlates to clinical outcome in stroke.
Spescha RD, Klohs J, Semerano A, Giacalone G, Derungs RS, Reiner MF, Rodriguez Gutierrez D, Mendez-Carmona N, Glanzmann M, Savarese G, Kränkel N, Akhmedov A, Keller S, Mocharla P, Kaufmann MR, Wenger RH, Vogel J, Kulic L, Nitsch RM, Beer JH, Peruzzotti-Jametti L, Sessa M, Lüscher TF, Camici GG.
Eur Heart J. 2015;1;36(25):1590-600.

Safety profile of prasugrel and clopidogrel in patients with acute coronary syndromes in Switzerland.
Klingenberg R, Heg D, Räber L, Carballo D, Nanchen D, Gencer B, Auer R, Jaguszewski M, Stähli BE, Jakob P, Templin C, Stefanini GG, Meier B, Vogt P, Roffi M, Maier W, Landmesser U, Rodondi N, Mach F, Windecker S, Jüni P, Lüscher TF, Matter CM.
Heart. 2015;101(11):854-63.

Genetic deletion of the adaptor protein p66Shc increases susceptibility to short-term ischaemic myocardial injury via intracellular salvage pathways.
Akhmedov A, Montecucco F, Braunersreuther V, Camici GG, Jakob P, Reiner MF, Glanzmann M, Burger F, Paneni F, Galan K, Pelli G, Vuilleumier N, Belin A, Vallée JP, Mach F, Lüscher TF.
Eur Heart J. 2015;21;36(8):516-26.

Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study.
Räber L, Taniwaki M, Zaugg S, Kelbæk H, Roffi M, Holmvang L, Noble S, Pedrazzini G, Moschovitis A, Lüscher TF, Matter CM, Serruys PW, Jüni P, Garcia-Garcia HM, Windecker S; IBIS 4 (Integrated Biomarkers and Imaging Study-4) Trial Investigators (NCT00962416).
Eur Heart J. 2015;21;36(8):490-500.

Adverse epigenetic signatures by histone methyltransferase set7 contribute to vascular dysfunction in patients with type 2 diabetes mellitus.
Paneni F, Costantino S, Battista R, Castello L, Capretti G, Chiandotto S, Scavone G, Villano A, Pitocco D, Lanza G, Volpe M, Lüscher TF, Cosentino F.
Circ Cardiovasc Genet. 2015;8(1):150-8.

The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study.
Ponikowski P, Filippatos G, Colet JC, Willenheimer R, Dickstein K, Lüscher T, Gaudesius G, von Eisenhart Rothe B, Mori C, Greenlaw N, Ford I, Macdougall I, Anker SD; for the FAIR-HF Trial Investigators.
Eur J Heart Fail. 2015;17(3):329-39.

Rapid and Body Weight-Independent Improvement of Endothelial and High-Density Lipoprotein Function After Roux-en-Y Gastric Bypass: Role of Glucagon-Like Peptide-1.
Osto E, Doytcheva P, Corteville C, Bueter M, Dörig C, Stivala S, Buhmann H, Colin S, Rohrer L, Hasballa R, Tailleux A, Wolfrum C, Tona F, Manz J, Vetter D, Spliethoff K, Vanhoutte PM, Landmesser U, Pattou F, Staels B, Matter CM, Lutz TA, Lüscher TF.
Circulation. 2015;10;131(10):871-81.

Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin.
Kühnast S, van der Tuin SJ, van der Hoorn JW, van Klinken JB, Simic B, Pieterman E, Havekes LM, Landmesser U, Lüscher TF, Willems van Dijk K, Rensen PC, Jukema JW, Princen HM.
Eur Heart J. 2015;1;36(1):39-48.

Genetic deletion of the adaptor protein p66Shc increases susceptibility to short-term ischaemic myocardial injury via intracellular salvage pathways
Akhmedov A., Montecucco F, Braunersreuther V, Camici GG, Jacob, Reiner MF, Glanzmann M, Burger F, Paneni F, Galan K, Pelli G, Vuilleumier N, Belin A, Vallée J-P, Mach F, Lüscher TF.
Eur Heart J. 2015;36: 516-26.

Incidence and prognosis of ventricular arrhythmias in patients with congenital left ventricular aneurysms or diverticula.
Haegeli LM, Ercin E, Steffel J, Wolber T, Tanner FC, Jenni R, Gämperli O, Saguner AM, Lüscher TF, Brunckhorst C, Duru F.
Am J Med. 2015 128(6):653

Targeting prolyl-isomerase Pin1 prevents mitochondrial oxidative stress and vascular dysfunction: insights in patients with diabetes.
Paneni F, Costantino S, Castello L, Battista R, Capretti G, Chiandotto S, D'Amario D, Scavone G, Villano A, Rustighi A, Crea F, Pitocco D, Lanza G, Volpe M, Del Sal G, Lüscher TF, Cosentino F.
Eur Heart J. 2015;36(13):817-28.

Clonal restriction and predominance of regulatory T cells in coronary thrombi of patients with acute coronary syndromes.
Klingenberg R, Brokopp CE, Grivès A, Courtier A, Jaguszewski M, Pasqual N, Vlaskou Badra E, Lewandowski A, Gaemperli O, Hoerstrup SP, Maier W, Landmesser U, Lüscher TF, Matter CM.
Eur Heart J. 2015;36(17):1041-8.

High-density lipoprotein from patients with coronary heart disease loses anti-thrombotic effects on endothelial cells: impact on arterial thrombus formation.
Holy EW, Besler C, Reiner MF, Camici GG, Manz J, Beer JH, Lüscher TF, Landmesser U, Tanner FC.
Thromb Haemost. 2014;112(5):1024-35.

Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011-2012 Pilot European Sentinel Registry.
Nickenig G, Estevez-Loureiro R, Franzen O, Tamburino C, Vanderheyden M, Lüscher TF, Moat N, Price S, Dall'Ara G, Winter R, Corti R, Grasso C, Snow TM, Jeger R, Blankenberg S, Settergren M, Tiroch K, Balzer J, Petronio AS, Büttner HJ, Ettori F, Sievert H, Fiorino MG, Claeys M, Ussia GP, Baumgartner H, Scandura S, Alamgir F, Keshavarzi F, Colombo A, Maisano F, Ebelt H, Aruta P, Lubos E, Plicht B, Schueler R, Pighi M, Di Mario C; Transcatheter Valve Treatment Sentinel Registry Investigators of the EURObservational Research Programme of the European Society of Cardiology.
J Am Coll Cardiol. 2014;2;64(9):875-84.

Adaptor protein p66(Shc) mediates hypertension-associated, cyclic stretch-dependent, endothelial damage.
Spescha RD, Glanzmann M, Simic B, Witassek F, Keller S, Akhmedov A, Tanner FC, Lüscher TF, Camici GG.
Hypertension. 2014;64(2):347-53.

Treatment with higher dosages of heart failure medication is associated with improved outcome following cardiac resynchronization therapy.
Schmidt S, Hürlimann D, Starck CT, Hindricks G, Lüscher TF, Ruschitzka F, Steffel J.
Eur Heart J. 2014;35(16):1051-60.

PI3K/p110α inhibition selectively interferes with arterial thrombosis and neointima formation, but not re-endothelialization: potential implications for drug-eluting stent design.
Holy EW, Jakob P, Eickner T, Camici GG, Beer JH, Akhmedov A, Sternberg K, Schmitz KP, Lüscher TF, Tanner FC.
Eur Heart J. 2014;35(12):808-20.

Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial.
Tardif JC, Ballantyne CM, Barter P, Dasseux JL, Fayad ZA, Guertin MC, Kastelein JJ, Keyserling C, Klepp H, Koenig W, L'Allier PL, Lespérance J, Lüscher TF, Paolini JF, Tawakol A, Waters DD; Can HDL Infusions Significantly QUicken Atherosclerosis REgression (CHI-SQUARE) Investigators.
Eur Heart J. 2014;7;35(46):3277-86

Essential role of sympathetic endothelin A receptors for adverse cardiac remodeling.
Lehmann LH, Rostosky JS, Buss SJ, Kreusser MM, Krebs J, Mier W, Enseleit F, Spiger K, Hardt SE, Wieland T, Haass M, Lüscher TF, Schneider MD, Parlato R, Gröne HJ, Haberkorn U, Yanagisawa M, Katus HA, Backs J.
Proc Natl Acad Sci U S A. 2014;16;111(37):13499-504.

Recovery mismatch between myocardial blood flow and cardiac workload after physical exercise: a positron emission tomography study.
Siegrist PT, Koepfli P, Namdar M, Pazhenkottil AP, Nkoulou R, Lüscher TF, Kaufmann PA.
Eur Heart J Cardiovasc Imaging. 2014;15(12):1386-90.

A signature of circulating microRNAs differentiates takotsubo cardiomyopathy from acute myocardial infarction.
Jaguszewski M, Osipova J, Ghadri JR, Napp LC, Widera C, Franke J, Fijalkowski M, Nowak R, Fijalkowska M, Volkmann I, Katus HA, Wollert KC, Bauersachs J, Erne P, Lüscher TF, Thum T, Templin C.
Eur Heart J. 2014;35(15):999-1006.

Carbamylated low-density lipoprotein induces endothelial dysfunction.
Speer T, Owala FO, Holy EW, Zewinger S, Frenzel FL, Stähli BE, Razavi M, Triem S, Cvija H, Rohrer L, Seiler S, Heine GH, Jankowski V, Jankowski J, Camici GG, Akhmedov A, Fliser D, Lüscher TF, Tanner FC.
Eur Heart J. 2014;14;35(43):3021-32.

The Sirt1 activator SRT3025 provides atheroprotection in Apoe-/- mice by reducing hepatic Pcsk9 secretion and enhancing Ldlr expression.
Miranda MX, van Tits LJ, Lohmann C, Arsiwala T, Winnik S, Tailleux A, Stein S, Gomes AP, Suri V, Ellis JL, Lutz TA, Hottiger MO, Sinclair DA, Auwerx J, Schoonjans K, Staels B, Lüscher TF, Matter CM.
Eur Heart J. 2015;1;36(1):51-9.

First three-dimensional optical frequency domain imaging evaluation of a bioabsorbable vascular scaffold implantation in an instent-restenosis 6 years after CYPHER stenting.
Jaguszewski M, Obeid S, Lüscher TF, Templin C.
Eur Heart J. 2014;1;35(21):1393.

Different prognostic value of functional right ventricular parameters in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
Saguner AM, Vecchiati A, Baldinger SH, Rüeger S, Medeiros-Domingo A, Mueller-Burri AS, Haegeli LM, Biaggi P, Manka R, Lüscher TF, Fontaine G, Delacrétaz E, Jenni R, Held L, Brunckhorst C, Duru F, Tanner FC.
Circ Cardiovasc Imaging. 2014;1;7(2):230-9.

Deletion of Sirt3 does not affect atherosclerosis but accelerates weight gain and impairs rapid metabolic adaptation in LDL receptor knockout mice: implications for cardiovascular risk factor development.
Winnik S, Gaul DS, Preitner F, Lohmann C, Weber J, Miranda MX, Liu Y, van Tits LJ, Mateos JM, Brokopp CE, Auwerx J, Thorens B, Lüscher TF, Matter CM.
Basic Res Cardiol. 2014;109(1):399.

Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling.
Riwanto M, Rohrer L, Roschitzki B, Besler C, Mocharla P, Mueller M, Perisa D, Heinrich K, Altwegg L, von Eckardstein A, Lüscher TF, Landmesser U.
Circulation. 2013;127(8):891-904.

Abnormal high-density lipoprotein induces endothelial dysfunction via activation of Toll-like receptor-2.
Speer T, Rohrer L, Blyszczuk P, Shroff R, Kuschnerus K, Kränkel N, Kania G, Zewinger S, Akhmedov A, Shi Y, Martin T, Perisa D, Winnik S, Müller MF, Sester U, Wernicke G, Jung A, Gutteck U, Eriksson U, Geisel J, Deanfield J, von Eckardstein A, Lüscher TF, Fliser D, Bahlmann FH, Landmesser U.
Immunity. 2013;38(4):754-68.

Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function.
Sürder D, Manka R, Lo Cicero V, Moccetti T, Rufibach K, Soncin S, Turchetto L, Radrizzani M, Astori G, Schwitter J, Erne P, Zuber M, Auf der Maur C, Jamshidi P, Gaemperli O, Windecker S, Moschovitis A, Wahl A, Bühler I, Wyss C, Kozerke S, Landmesser U, Lüscher TF, Corti R.
Circulation. 2013;14;127(19):1968-79.

Endothelial mineralocorticoid receptor activation mediates endothelial dysfunction in diet-induced obesity.
Schäfer N, Lohmann C, Winnik S, van Tits LJ, Miranda MX, Vergopoulos A, Ruschitzka F, Nussberger J, Berger S, Lüscher TF, Verrey F, Matter CM.
Eur Heart J. 2013;34(45):3515-24.

Novel insights into the critical role of bradykinin and the kinin b2 receptor for vascular recruitment of circulating endothelial repair-promoting mononuclear cell subsets: alterations in patients with coronary disease.
Kränkel N, Kuschnerus K, Müller M, Speer T, Mocharla P, Madeddu P, Bader M, Lüscher TF, Landmesser U.
Circulation. 2013;127(5):594-603.

Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis.
Klingenberg R, Gerdes N, Badeau RM, Gisterå A, Strodthoff D, Ketelhuth DF, Lundberg AM, Rudling M, Nilsson SK, Olivecrona G, Zoller S, Lohmann C, Lüscher TF, Jauhiainen M, Sparwasser T, Hansson GK.
J Clin Invest. 2013;123(3):1323-34.

Real-time left ventricular pressure-volume loops during percutaneous mitral valve repair with the MitraClip system.
Gaemperli O, Biaggi P, Gugelmann R, Osranek M, Schreuder JJ, Bühler I, Sürder D, Lüscher TF, Felix C, Bettex D, Grünenfelder J, Corti R.
Circulation. 2013;127(9):1018-27.

Haemodynamically irrelevant pericardial effusion is associated with increased mortality in patients with chronic heart failure.
Fröhlich GM, Keller P, Schmid F, Wolfrum M, Osranek M, Falk C, Noll G, Enseleit F, Reinthaler M, Meier P, Lüscher TF, Ruschitzka F, Tanner FC.
Eur Heart J. 2013;34(19):1414-23.

The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study.
Comin-Colet J, Lainscak M, Dickstein K, Filippatos GS, Johnson P, Lüscher TF, Mori C, Willenheimer R, Ponikowski P, Anker SD.
Eur Heart J. 2013;34(1):30-8.

Deletion of the activated protein-1 transcription factor JunD induces oxidative stress and accelerates age-related endothelial dysfunction.
Paneni ., Osto E, Costantino S, Mateescu B, Briand S, Coppolino G, Perna E, Mocharla P, Akhmedov A, Kubant R, Rohrer L, Malinski T, Camici GG, Matter CM, Mechta-Grigoriou F, Volpe M, Lüscher TF, Cosentino F.
Circulation. 2013;127(11):1229-40.

Vascular lesions induced by renal nerve ablation as assessed by optical coherence tomography: pre- and post-procedural comparison with the Simplicity® catheter system and the EnligHTN™ multi-electrode renal denervation catheter.
Templin C, Jaguszewski M, Ghadri JR, Sudano I, Gaehwiler R, Hellermann JP, Schoenenberger-Berzins R, Landmesser U, Erne P, Noll G, Lüscher TF.
Eur Heart J. 2013;34(28):2141–8.

AngiomiR-126 expression and secretion from circulating CD34+ and CD14+ PBMCs: role for pro-angiogenic effects and alterations in type-2 diabetics.
Mocharla P, Briand S, Giannotti G, Dörries C, Jakob P, Paneni F, Lüscher TF, Landmesser U.
Blood. 2013;121:226-36.

Deletion of the ageing gene p66Shc reduces early stroke size following ischaemia/reperfusion brain injury.
Spescha RD, Shi Y, Wegener S, Keller S, Weber B, Wyss MM, Lauinger N, Tabatabai G, Paneni F, Cosentino F, Hock C, Weller M, Nitsch RM, Lüscher TF, Camici GG.
Eur. Heart J. 2013;34:96-103.

Nitric oxide synthase 2 is required for conversion of pro-fibrogenic inflammatory CD133+ progenitors into F4/80+ macrophages in experimental autoimmune myocarditis.
Blyszczuk P, Berthonneche C, Behnke S, Glönkler M, Moch H, Pedrazzini T, Lüscher TF, Eriksson U, Kania G.
Cardiovasc Res. 2013;97:219-29.

Registry for the evaluation of the PROgnostic value of a novel integrated imaging approach combining Single Photon Emission Computed Tomography with coronary calcification imaging (REPROSPECT).
Ghadri JR, Fiechter M, Fuchs TA, Scherrer A, Stehli J, Gebhard C, Kläser B, Gaemperli O, Lüscher TF, Templin C, Kaufmann PA.
Eur. Heart J. Cardiovasc. Imaging 2013;14:374-380.

Loss of AngiomiR-126 and 130a in angiogenic early outgrowth cells from patients with chronic heart failure: Role for impaired in vivo neovascularization and cardiac repair capacity.
Jakob P, Doerries C, Briand S, Mocharla P, Kränkel N, Besler C, Mueller M, Manes C, Templin C, Baltes C, Rudin M, Adams H, Wolfrum M, Noll G, Ruschitzka F, Lüscher TF, Landmesser U.
Circulation. 2012;126:2962-75.

Dronedarone reduces arterial thrombus formation.
Breitenstein A, Sluka SH, Akhmedov A, Stivala S, Steffel J, Camici GG, Riem HH, Beer HJ, Studt SD, Duru F, Luscher TF, Tanner FC.
Basic Res Cardiol. 2012;107:302.

Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial.
Räber L, Kelbæk H, Ostojic M, Baumbach A, Heg D, Tüller D, von Birgelen C, Roffi M, Moschovitis A, Khattab AA, Wenaweser P, Bonvini R, Pedrazzini G, Kornowski R, Weber K, Trelle S, Lüscher TF, Taniwaki M, Matter CM, Meier B, Jüni P, Windecker S; COMFORTABLE AMI Trial Investigators.
JAMA. 2012;308:777-87.

Torcetrapib impairs endothelial function in hypertension.
Simic B, Hermann M, Shaw SG, Bigler L, Stalder U, Dörries C, Besler C, Lüscher TF, Ruschitzka F.
Eur Heart J. 2012;33:1615-24.

Gene silencing of the mitochondrial adaptor p66(Shc) suppresses vascular hyperglycemic memory in diabetes.
Paneni F, Mocharla P, Akhmedov A, Costantino S, Osto E, Volpe M, Lüscher TF, Cosentino F.
Circ Res. 2012;111:278-89.

Vascular effects and safety of dalcetrapib in patients with or at risk of coronary heart disease: the dal-VESSEL randomized clinical trial.
Lüscher TF, Taddei S, Kaski JC, Jukema JW, Kallend D, Münzel T, Kastelein JJ, Deanfield JE; dal-VESSEL Investigators.
Eur Heart J. 2012;33:857-65.

Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction.
Kalesan B, Pilgrim T, Heinimann K, Räber L, Stefanini GG, Valgimigli M, da Costa BR, Mach F, Lüscher TF, Meier B, Windecker S, Jüni P.
Eur Heart J. 2012;33:977-87.

Acute haemodynamic changes after percutaneous mitral valve repair: relation to mid-term outcomes.
Gaemperli O, Moccetti M, Surder D, Biaggi P, Hurlimann D, Kretschmar O, Buehler I, Bettex D, Felix C, Luscher TF, Falk V, Grunenfelder J, Corti R.
Heart. 2012;98:126-32.

Expression of the aging gene p66Shc is increased in peripheral blood monocytes of patients with acute coronary syndrome but not with stable coronary artery disease.
Franzeck FC, Hof D, Spescha RD, Hasun M, Akhmedov A, Steffel J, Shi Y, Cosentino F, Tanner FC, von Eckardstein A, Maier W, Lüscher TF, Wyss CA, Camici GG.
Atherosclerosis. 2012;220:282-6.

Cardiovascular effects of flavanol-rich chocolate in patients with heart failure.
Flammer AJ, Sudano I, Wolfrum M, Thomas R, Enseleit F, Périat D, Kaiser P, Hirt A, Hermann M, Serafini M, Lévêques A, Lüscher TF, Ruschitzka F, Noll G, Corti R.
Eur Heart J. 2012;33:2172-80.

Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over study.
Enseleit F, Sudano I, Périat D, Winnik S, Wolfrum M, Flammer AJ, Fröhlich GM, Kaiser P, Hirt A, Haile SR, Krasniqi N, Matter CM, Uhlenhut K, Högger P, Neidhart M, Lüscher TF, Ruschitzka F, Noll G.
Eur Heart J. 2012;33:1589-97.

Characteristics and long-term outcome of echocardiographic super-responders to cardiac resynchronisation therapy: 'real world' experience from a single tertiary care centre.
J. Steffel, G. Milosevic, A. Hürlimann, N. Krasniqi, M. Namdar, F. Ruschitzka, T.F. Lüscher, F. Duru, J. Holzmeister, D. Hürlimann.
Heart. 2011;97:1668-74.

Transcatheter aortic valve implantation (TAVI) outcome according to standardized endpoint definitions by the Valve Academic Research Consortium (VARC).
B.E. Stähli, R. Bünzli, J. Grünenfelder, I. Bühler, C. Felix, D. Bettex, P. Biaggi, F.C. Tanner, D.L. Nguyen-Kim, A. Plass, H. Ge, V. Falk, T.F. Lüscher, R. Corti, W. Maier, L.A. Altwegg.
J Invasive Cardiol. 2011;23:307-312.

Nebivolol exerts beneficial effects on endothelial function, early endothelial progenitor cells, myocardial neovascularization, and left ventricular dysfunction early after myocardial infarction beyond conventional β1-blockade.
S.A. Sorrentino, C. Doerries, C. Manes, T. Speer, C. Dessy, I. Lobysheva,
W. Mohmand, R. Akbar, F. Bahlmann, C. Besler, A. Schaefer, D. Hilfiker-Kleiner, T.F. Lüscher, J.L. Balligand, H. Drexler, U. Landmesser.
J Am Coll Cardiol. 2011;57:601-11.

Myeloid related proteins activate Toll-like receptor 4 in human acute coronary syndromes.
K. Yonekawa, M. Neidhart, L.A. Altwegg, C.A. Wyss, R. Corti, T. Vogl, M. Grigorian, S. Gay, T.F. Lüscher, W. Maier.
Atherosclerosis. 2011;218:486-92.

Impact of cardiac hybrid single-photon emission computed tomography/computed tomography imaging on choice of treatment strategy in coronary artery disease.
A.P. Pazhenkottil, R. NkoulouN, J.R. Ghadri, B.A. Herzog, S.M. Küest, L. Husmann, M. Wolfrum, R. Goetti, R.R. Buechel, O. Gaemperli, T.F. Lüscher, P.A. Kaufmann.
Eur Heart J. 2011;32:2824-9.

Arrhythmic manifestations in patients with congenital left ventricular aneurysms and diverticula.
L.M. Haegeli, E. Ercin, T. Wolber, C. Brunckhorst, F.C. Tanner, R. Jenni, T.F. Lüscher, F. Duru.
Am J Cardiol. 2011;108:1826-30.

Oxidized low density lipoprotein (oxLDL) mediated p66shc activation and reactive oxygen species (ROS) production goes through lectin-like oxidized LDL receptor-1 (LOX-1) and mediated by protein kinase C beta and c-Jun N-terminal kinase in human aortic endothelial cells.
Y. Shi, F. Cosentino, G.G. Camici, A. Akhmedov, P.M. Vanhoutte, F.C. Tanner, T.F. Lüscher.
Arterioscler Thromb Vasc Biol. 2011;31:2090-7.

Dietary α-linolenic acid diminishes experimental atherogenesis and restricts T cell-driven inflammation.
S. Winnik, C. Lohmann, E.K. Richter, N. Schäfer, W.L. Song, F. Leiber, P. Mocharla, J. Hofmann, R. Klingenberg, J. Borén, B. Becher, G.A. Fitzgerald, T.F. Lüscher, C.M. Matter, J.H. Beer.
Eur Heart J. 2011;32:2573-84.

Sirt1 inhibition promotes in vivo arterial thrombosis and tissue factor expression in stimulated cells.
A. Breitenstein, S. Stein, E.W. Holy, G.G. Camici, C. Lohmann, A. Akhmedov, R. Spescha, P.J. Elliott, C.H. Westphal, C.M. Matter, T.F. Lüscher, F.C. Tanner.
Cardiovasc Res. 2011;89:464-72.

Mechanisms underlying adverse effects of highdensity lipoprotein on endothelial NO synthaseactivating pathways in coronary artery disease.
C. Besler, K. Heinrich, L. Rohrer, C. Doerries, M. Riwanto, D.M. Shih, A. Chroni, K. Yonekawa, S. Stein, N. Schaefer, M. Mueller, A. Akhmedov, C. Manes, C. Wyss, W. Maier, F.C. Tanner, C.M. Matter, R. Corti, C.Furlong, A.J. Lusis, A. von Eckardstein, A.M. Fogelman, T.F. Lüscher, U. Landmesser.
J Clin Invest. 2011;121:2693-708.

Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata.
C.E. Brokopp, R. Schoenauer, P. Richards, S. Bauer, C. Lohmann, M.Y. Emmert, B. Weber, S. Winnik, E. Aikawa, K. Graves, M. Genoni, P. Vogt, T.F. Lüscher, C. Renner, S.P. Hoerstrup, C.M. Matter.
Eur Heart J. 2011;32:2713-22.

Histamine receptor promotes atherosclerotic lesion formation by increasing vascular permeability for low-density lipoproteins.
I. Rozenberg, S.H. Sluka, L. Rohrer, J. Hofmann, B. Becher, A. Akhmedov, J. Soliz, P. Mocharla, J. Borén, P. Johansen, J. Steffel, T. Watanabe, T.F. Lüscher, F.C. Tanner.
Arterioscler Thromb Vasc Biol. 2010;30: 923-30.

Spontanous periodic breathing is associated with sympathetic hyperreactivity and baroreceptor dysfunction in hypertension.
C. Binggeli, I. Sudano, R. Corti, L. Spieker, R. Jenni, T.F. Lüscher, F. Noll.
J Hypertens. 2010;28:985-92.

Coronary optical frequency domain imaging (OFDI) for in vivo evaluation of stent healing: comparison with light and electron microscopy.
C. Templin, M. Meyer, M.F. Müller, V. Djonov, R. Hlushchuk, I. Dimova, S. Flueckiger, P. Kronen, M. Sidler, K. Klein, F. Nicholls, J.R. Ghadri, K. Weber, D. Paunovic, R. Corti, S.P. Hoerstrup, T.F. Lüscher, U. Landmesser.
Eur Heart J. 2010;31:1792-801.

Implantable cardioverter-defibrillator and cardiac resynchronization therapy in patients with left ventricular noncompaction.
R. Kobza R, J. Steffel, P. Erne, A.W. Schoenenberger, D. Hürlimann, T.F. Lüscher, R. Jenni, F. Duru.
Heart Rhythm. 2010;7:1545-9.

Impaired endothelial repair capacity of early endothelial progenitor cells in prehypertension: relation to endothelial dysfunction.
G. Giannotti, C. Doerries, P.S. Mocharla, M.F. Mueller, F.H. Bahlmann, T. Horvàth, H. Jiang, S.A. Sorrentino, N. Steenken, C. Manes, M. Marzilli, K.L. Rudolph, T.F. Lüscher, H. Drexler, U. Landmesser.
Hypertension. 2010;55:1389-97.

Cellular actors, Toll-like receptors, and local cytokine profile in acute coronary syndromes.
C.A. Wyss, M. Neidhart, L. Altwegg, K.S. Spanaus, K. Yonekawa, M.B. Wischnewsky, R. Corti, N. Kucher, M. Roffi, F.R. Eberli, B. Amann-Vesti, S. Gay, A. von Eckardstein, T.F. Lüscher, W. Maier.
Eur Heart J. 2010;31:1457-69.

Performance of simultaneous cardiac-respiratory self-gated three-dimensional MR imaging of the heart, initial experience.
R. Manka, M. Buehrer, P. Boesiger, E. Fleck, S. Kozerke.
Radiology. 2010;255:909-16.

Upgrading to resynchronization therapy after chronic right ventricular pacing improves left ventricular remodelling.
G. Fröhlich, J. Steffel, D. Hürlimann, F. Enseleit, T.F. Lüscher, F. Ruschitzka, W.T. Abraham, J. Holzmeister.
Eur Heart J. 2010;31:1477-85.

Aging induces endothelial dysfunction while sparing arterial thrombosis.
S.F. Stämpfli, A. Akhmedov, C. Gebhard, C. Lohmann, E.W. Holy, I. Rozenberg, R. Spescha, Y. Shi, T.F. Lüscher, F.C. Tanner, G.G. Camici.
Arterioscler Thromb Vasc Biol. 2010;30:1960-7.

Acetaminophen increases blood pressure in patients with coronary artery disease.
I. Sudano, A.A.J. Flammer, D. Périat, F. Enseleit, M. Hermann, M. Wolfrum, A. Hirt, P. Kaiser, D. Hurlimann, M. Neidhart, S. Gay, J. Holzmeister, J. Nussberger, P. Mocharla, U. Landmesser, S.R. Haile, R. Corti, P.M. Vanhoutte, T.F. Lüscher, G. Noll, F. Ruschitzka.
Circulation. 2010;122:1789-96.

SIRT1 decreases LOX-1-mediated foam cell formation in atherogenesis.
S. Stein, C. Lohmann, N. Schäfer, J. Hofmann, L. Rohrer, C. Besler, K.M. Rothgiesser, B. Becher, M.O. Hottiger, J. Borén, M.W. McBurney, C. Handschin, U. Landmesser, T.F. Lüscher, C.M. Matter.
Eur Heart J. 2010;31:2301-9.

Impact of stent overlap on angiographic and long-term clinical outcome in patients undergoing drug-eluting stent implantation.
L. Räber, P. Jüni, L. Löffel, S. Wandel, S. Cook, P. Wenaweser, M. Togni, R. Vogel, C. Seiler, F. Eberli, T.F. Lüscher, B. Meier, S. Windecker.
J Am Coll Cardiol. 2010;23:1178-88.

PQ-interval shortening in patients with Fabry Disease.
M. Namdar, C. Kampmann, J. Steffel, D. Walder, J. Holzmeister, T.F. Lüscher, R. Jenni, F. Duru.
Am J Cardiol. 2010;105:753-6.

Laminin receptor activation inhibits endothelial tissue factor expression.
E.W. Holy, S.F. Stämpfli, A. Akhmedov, N. Holm, G.G. Camici, T.F. Lüscher,
F.C. Tanner.
J Mol Cell Cardiol. 2010;48:1138-45.

Impaired endothelial repair capacity of early endothelial progenitor cells in prehypertension – relation to endothelial dysfunction.
G. Giannotti, C. Doerries, P. Mocharla, M. Mueller, T. Horvàth, H. Jiang, S.A. Sorrentino, C. Manes, M. Marzilli, K.L. Rudolph, T.F. Lüscher, H. Drexler, U. Landmesser.
Hypertension. 2010;55:1389-97.

Rapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus eluting stents.
G.G. Camici, J. Steffel, I. Amanovic, A. Breitenstein, J. Baldinger, S. Keller, T.F. Lüscher, F.C. Tanner.
Eur Heart J. 2010;31:236-42.

Heart-infiltrating prominin-1+/CD133+ progenitor cells represent the cellular source of transforming growth factor beta-mediated cardiac fibrosis in experimental autoimmune myocarditis.
G. Kania, P. Blyszczuk, S. Stein, A. Valaperti, D. Germano, S. Dirnhofer, L. Hunziker, C.M. Matter, U. Eriksson.
Circ Res. 2009;105:462-70.

A randomized placebo-controlled study on the effect of nifedipine on coronary endothelial function and plaque formation in patients with coronary artery disease: the ENCORE II study.
T.F. Lüscher, M. Pieper, M. Tendera, M. Vrolix, W. Rutsch, F. van den Branden, R. Gil, K.O. Bischoff, M. Haude, D. Fischer, T. Meinertz, T. Münzel.
Eur Heart J. 2009;30:1556-8.

Atherosclerotic mice exhibit systemic inflammation in periadventitial and visceral adipose tissue, liver, and pancreatic islets.
C. Lohmann, N. Schäfer, T. von Lukowicz, M.A. Sokrates Stein, J. Borén, S. Rütti, W. Wahli, M.Y. Donath, T.F. Lüscher, C.M. Matter.
Atherosclerosis. 2009;207:360-7.

Cholesterylestertransfer protein inhibition and endothelial function in type II hyperlipidemia.
F. Hermann, F. Enseleit, L.E. Spieker, D. Périat, I. Sudano, M. Hermann, R. Corti, G. Noll, F.T. Ruschitzka, T.F. Lüscher.
Thromb Res. 2009;123:460-465.

Heart transplantation in adolescent and adult patients with congenital heart disease: a case-control study.
M. Greutmann, R. Prêtre, L. Furrer, U. Bauersfeld, M. Turina, G. Noll, T. F. Lüscher, P.T. Trindade.
Transplant Proc. 2009;41:3821-6.

Coronary CT angiography and myocardial perfusion imaging to detect flow-limiting stenoses: a potential gatekeeper for coronary revascularization?
O. Gaemperli, L. Husmann, T. Schepis, P. Koepfli, I. Valenta, W. Jenni, H. Alkadhi, T.F. Lüscher, P.A. Kaufmann.
Eur Heart J. 2009;30:2921-9.

Effect of atazanavir versus other protease inhibitor-containing antiretroviral therapy on endothelial function in HIV-infected persons: randomised controlled trial.
A.A.J. Flammer, N.T. Vo, B. Ledergerber, F. Hermann, A. Gämperli, A. Huttner, J. Evison, I. Baumgartner, M. Cavassini, D. Hayoz, K. Quitzau, M. Hersberger, I. Sudano, F. Ruschitzka, T.F. Lüscher, G. Noll, R. Weber.
Heart. 2009;95:385-90.

Vascular abnormalities, paraoxonase activity, and dysfunctional HDL in primary antiphospholipid syndrome.
M. Charakida, C. Besler, JR Batuca, S. Sangle, S Marques, M. Sousa, G. Wang, D. Tousoulis, J. Delgado Alves, S.P. Loukogeorgakis, C. Mackworth-Young, D. D'Cruz, T.F. Luscher, U. Landmesser, J.E. Deanfield.
JAMA. 2009;302:1210-17.

Decreased umbilical artery compliance and igf-I plasma levels in infants with intrauterine growth restriction – implications for fetal programming of hypertension.
T. Burkhardt, C.M. Matter, C. Lohmann, H. Cai, T.F. Lüscher, A.H. Zisch, E. Beinder.
Placenta. 2009;30:136-41.

Myeloid differentiation factor-88 / interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy.
P. Blyszczuk, G. Kania, T. Dieterle, R.R. Marty, A. Valaperti, C. Berthonneche, T. Pedrazzini, C.T. Berger, S. Dirnhofer, C.M. Matter, J.M. Penninger, T.F. Lüscher, U. Eriksson.
Circ Res. 2009;105:912-20.

Ferric carboxymaltose in patients with heart failure and iron deficiency.
S.D. Anker, J. Comin Colet, G. Filippatos, R. Willenheimer, K. Dickstein, H. Drexler, T.F. Lüscher, B. Bart, W. Banasiak, J. Niegowska, B.A. Kirwa, C. Mori, B. von Eisenhart Rothe, S.J. Pocock, P.A. Poole-Wilson, P. Ponikowski; for the FAIR-HF Trial Investigators.
N Engl J Med. 2009;361:2436-48.

PROGRESS-AMS (Clinical Performance Angiographic Results of Coronary Stenting with Absorbable Metal Stents) Investigators. Early- and long-term intravascular ultrasound and angiographic findings after bioabsorbable magnesium stent implantation in human coronary arteries.
R. Waksman, R. Erbel, C. Di Mario, J. Bartunek, B. de Bruyne, F.R. Eberli, P. Erne, M. Haude, M. Horrigan, C. Ilsley, D. Böse, H. Bonnier, J. Koolen, T.F. Lüscher, N.J. Weissman.
JACC Cardiovasc Interv. 2009;2:312-20.

Combining dual-source computed tomography coronary angiography and calcium scoring: added value for the assessment of coronaryartery disease.
Leschka, H. Scheffel, L. Desbiolles, A. Plass, O. Gaemperli, P. Stolzmann, M. Genoni, T.F. Lüscher, B. Marincek, P. Kaufmann, H. Alkadhi.
Heart. 2008;94:1154-61.

PARP1 is required for adhesion molecule expression in atherogenesis.
T. von Lukowicz, P.O. Hassa, C. Lohmann, J. Borén, V. Braunersreuther, F. Mach, O. Odermatt, M. Gersbach, G.G. Camici, B.E. Stähli, F.C. Tanner, M.O. Hottiger, T.F. Lüscher, C.M. Matter.
Cardiovasc Res. 2008;78:158-66.

Prothrombotic gene expression profile in vascular smooth muscle cells of human saphenous vein, but not internal mammary artery.
S.K. Payeli, R. Latini, C. Gebhard, A. Patrignani, U. Wagner, T.F. Lüscher, F.C. Tanner.
Arterioscler Thromb Vasc Biol. 2008;28:705-10.

Cardiac glycosides regulate endothelial tissue factor experession in culture.
B.E. Stähli, A. Breitenstein, A. Akhmedov, G. G. Camici, K. Shojaati, N. Bogdanov, D. Ringli, T.F. Lüscher, F.C. Tanner.
Arterioscl Thromb Vasc Biol. 2008;27:2769-76.

Low-dose CT coronary angiography in the step-and-shoot mode: diagnostic performance
H. Scheffel, H. Alkadhi, S. Leschka, A. Plass, L. Desbiolles, I. Guber, T. Krauss, J. Gruenenfelder, M. Genoni, T.F. Lüscher, B. Marincek, P. Stolzmann.
Heart. 2008;94:1132-7.

High spatial resolution myocardial perfusion cardiac magnetic resonance for the detection of coronary artery disease.
S. Plein, S. Kozerke, D. Suerder, T.F. Lüscher, J.P. Greenwood, P. Boesiger, J. Schwitter.
Eur Heart J. 2008;29:2148-55.

Prothrombotic gene expression profile in vascular smooth muscle cells of human saphenous vein, but not internal mammary artery.
S.K. Payeli, R. Latini, K. Gebhard, A. Patrignani, U. Wagner, T.F. Lüscher, F.C. Tanner.
Arterioscler Thromb Vasc Biol. 2008;28:705-10.

c-Jun N-terminal kinase 2 deficiency protects against hypercholesterolemia-induced endothelial dysfunction and oxidative stress.
E. Osto, C.M. Matter, A. Kouroedov, T. Malinski T, M. Bachschmid, G.G. Camici, U. Kilic, T. Stallmach, J. Boren, S. Iliceto, T.F. Lüscher, F. Cosentino.
Circulation. 2008;118:2073-80.

Inhibition of protein kinase Cbeta prevents foam cell formation by reducing scavenger receptor A expression in human macrophages.
E. Osto, A. Kuroedov, P. Mocharla, A. Akhmedov, C. Besler, L. Rohrer, A. von Eckardstein, S. Iliceto, M. Volpe, T.F. Lüscher, F. Cosentino.
Circulation. 2008;118:2174-82.

Combining dual-source computed tomography coronary angiography and calcium scoring: added value for the assessment of coronary artery disease
S. Leschka, H. Scheffel, L. Desbiolles, A. Plass, O. Gaemperli, P. Stolzman, M. Genoni, T.F. Lüscher, B. Marincek, P.A. Kaufman, H. Alkadhi.
Heart. 2008;94:1154-61.

Interaction of caffeine with regadenoson-induced hyperemic myocardial blood flow as measured by positron emission tomography: a randomized, double-blind, placebo-controlled crossover trial.
Gaemperli, T. Schepis, P. Koepfli, P. Siegrist, S. Fleischman, P. Nguyen, A. Olmsted, W. Wang, H. Lieu, P. Kaufmann.
J Amer Coll Cardiol. 2008;51:328-9.

Combining dual-source computed tomography coronary angiography and calcium scoring: added value for the assessment of coronary artery disease.
S. Leschka, H. Scheffel, L. Desbiolles, A. Plass, O. Gaemperli, P. Stolzman, M. Genoni, T.F. Lüscher, B. Marincek, P.A. Kaufman, H. Alkhadi.
Heart. 2008;94:1154-61.

Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis.
A.A.J. Flammer, I. Sudano, F. Hermann, S. Gay, A. Forster, M. Neidhart, P. Künzler, F. Enseleit, D. Périat, M. Hermann, J. Nussberger, T.F. Lüscher, R. Corti, G. Noll, F. Ruschitzka.
Circulation. 2008;117:2262-9.

Chronic Treatment with Tetrahydrobiopterin Reverses Endothelial Dysfunction and Oxidative Stress in Hypercholesterolemia.
F. Cosentino, D. Hürlimann, C. Delli Gatti, R. Chenevard, N. Blau, N.J. Alp, K.M. Channon, M. Eto, P. Lerch, F. Enseleit, F. Ruschitzka, M. Volpe, T.F. Lüscher, G. Noll.
Heart. 2008;94:487-92.

Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patients.
M. Billinger, J. Beutler, K.R. Taghetchian, A. Remondino, P. Wenaweser, S. Cook, M. Togni, C. Seiler, C. Stettler, F.R. Eberli, T.F. Lüscher, S.Wandel, P. Jüni, B. Meier, S. Windecker.
Eur Heart J. 2008;29:718-25.

Dual-source computed tomography coronary angiography: influence of obesity, calcium load, and heart rate on diagnostic accuracy.
H. Alkadhi, H. Scheffel, L. Desbiolles, O. Gaemperli, P. Stolzmann, A. Plass, G.W. Goerres, T.F. Lüscher, M. Genoni, B. Marincek, P.A. Kaufmann, S. Leschka.
Eur Heart J. 2008;29:766-76.

Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a subgroup analysis of the SIRTAX trial.
M. Togni, S. Eber, J. Widmer, M. Billinger, P. Wenaweser, S. Cook, R. Vogel, C. Seiler, F.R. Eberli, W. Maier, R. Corti, M. Roffi, T.F. Lüscher, A. Garachemani, O.M. Hess, S. Wandel, B. Meier, P. Jüni, S. Windecker.
J Am Coll Cardiol. 2007;50:1123-31.

Chronic treatment with long-acting nifedipine reduces vasoconstriction to endothelin-1 in essential hypertension.
I. Sudano, A. Virdis, S. Taddei, L. Spieker, R. Corti, G. Noll, A. Salvetti, T.F. Lüscher.
Hypertension. 2007;49:285-90.

Cardiac glycosides regulate endothelial tissue factor expression in culture.
B.E. Stähli, A. Breitenstein, A. Akhmedov, G.G. Camici, K. Shojaati, N. Bogdanov, J. Steffel, D. Ringli, T.F. Lüscher, F.C. Tanner.
Arterioscler Thromb Vasc Biol. 2007;27:2769-76.

Cyclophyllin A differentially activates monocytes and endothelial cells: Role of purity, activity, and endotoxin contamination in commercial preparations.
S.K. Payeli, C. Schiene-Fischer, J. Steffel, G.G. Camici, I. Rozenberg, T.F. Lüscher, F.C. Tanner.
Atherosclerosis. 2007;197:564-71.

Asymmetrical dimethylarginine (ADMA) and coronary endothelial function in patients with coronary artery disease and mild hypercholesterolemia.
R. Maas, K. Quitzau, E. Schwedhelm, L. Spieker, W. Rafflenbeul, A. Steenpass, T.F. Lüscher, R.H. Böger.
Atherosclerosis. 2007;191:211-19.

Systemic nitric oxide synthase inhibition improves coronary flow reserve to adenosine in patients with significant stenoses.
P.A. Kaufmann, O.E. Rimoldi, T. Gnecchi-Ruscone, T.F. Lüscher, P.G. Camici.
Am J Physiol Heart Circ Physiol. 2007;293:H2178-82.

Dark chocolate improves coronary vasomotion and reduces platelet reactivity.
A.A.J. Flammer, F. Hermann, I. Sudano, L. Spieker, M. Hermann, K.A. Cooper, M. Serafini, T.F. Lüscher, F. Ruschutzka, G. Noll, R. Corti.
Circulation. 2007;116:2376-82.

Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension.
A.A.J. Flammer, F. Hermann, P. Wiesli, B. Schwegler, R. Chenevard, D. Hürlimann, I. Sudano, S. Gay, M. Neidhart, W. Riesen, F. Ruschitzka, T.F. Lüscher, G. Noll, R. Lehmann.
J Hypertension. 2007;25:785-91.

Genetic deletion of p66Shc adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress.
G.C. Camici, M. Schiavoni, P. Francia, M. Bachschmid, I. Martin-Padura, M. Hersberger, F.C. Tanner, P.G. Pelicci, M. Volpe, P. Anversa, T.F. Lüscher, F. Cosentino.
Proc Natl Acad Sci. 2007;104:5217-22.

Myeloid-related protein 8/14 complex is released by monocytes and granulocytes at the site of coronary occlusion: a novel, early, and sensitive marker of acute coronary syndromes. (fasttrack)
L.A. Altwegg, M. Neidhart, M. Hersberger, S. Müller, F.R. Eberli, R. Corti, M. Roffi, G. Sütsch, S. Gay, A. von Eckardtstein, M.B. Wischnewsky, T.F. Lüscher, W. Maier.
Eur Heart J. 2007;28:941-8.

Paclitaxel enhances thrombin-induced endothelial tissue factor expression via c-jun terminal NH2 kinase activation.
B.E. Stähli, G.C. Camici, J. Steffel, A. Akhmedov, K. Shoojati, M. Graber, T.F. Lüscher, F.C. Tanner.
Circ Res. 2006;99:149-55.

C-reactive protein influences shear stress-dependent platelet adhesion in patients with familiar hypercholesterolemia and coronary artery disease undergoing LDL apherisis. (research letter)
L.E, Spieker, A.A.J. Flammer, N. Amacker, I. Sudano, J.J. Badimon, F. Ruschitzka, T.F. Lüscher, G. Noll, R. Corti.
Thromb Haemost. 2006;96:540-2.

Diabetes promotes cardiac stemm cell aging and heart failure, which are prevented by deletion of the p66shc gene.
M. Rota, N. LeCapitaine, T. Hosoda, A. Boni, A. De Angelis, M. E. Padin-Iruegas, G. Esposito, S. Vitale, K. Urbanek, C. Casarsa, M. Giorgio, T.F. Lüscher, P.G. Pelicci, P. Anversa, A. Leri, J. Kajstura.
Circulation. 2006;99;42-52.

Dimethyl sulfoxide inhibits tissue factor expression, thrombus formation, and vascular smooth muscle cell activation. A potential treatment strategy for drug-eluting stents.
G. Camici, J, Steffel, A. Akhmedov, N. Schafer, J. Baldinger, U. Schulz, K. Shojaati, C.M. Matter, Z. Yang, T.F. Lüscher, F.C. Tanner.
Circulation. 2006;114:1512-21.

Histamine differentially interacts with tumor necrosis factor-alpha and thrombin in endothelial tissue factor induction: Role of c-Jun terminal NH2 kinase.
J. Steffel, C. Arnet, A. Akhmedov, S.M. Iseli, T.F. Lüscher, F.C. Tanner.
J Thromb Haemost. 2006;11:2452-60.

Increased ballon-induced inflammation, proliferation and neointima formation in apolipoprotein E (ApoE) knockout mice.
C.M. Matter, L. Ma, T. von Lukowicz, P. Meier, C. Lohmann, D. Zhang, U. Kilic, E. Hofmann, S. Woo Ha, M. Hersberger, D.M. Hermann, T.F. Lüscher.
Stroke. 2006;36:2625-32.

Dimethyl sulfoxide inhibits tissue factor expression, thrombus formation and vascular smooth muscle activation: A potential treatment strategy for drug-eluting stents.
G.G. Camici, J. Steffel, A. Akhmedov, N. Schafer, J. Baldinger, U. Schulz, K. Shojaati, C.M. Matter, Z. Yang, T.F. Lüscher, F.C. Tanner.
Circulation. 2006;114:1512-21.

Reduced connexin43 expression limits neointima formation after balloon distension injury in hypercholesterolemic mice.
C.E. Chadjichristos, C.M. Matter, I. Roth, E. Sutter, G. Pelli, T.F. Lüscher, M. Chanson, B.R. Kwak.
Circulation. 2006;113:2835-43.

18F-Choline images murine atherosclerotic plaques ex vivo.
C.M. Matter, M.T. Wyss, P. Meier, N. Späth, T. von Lukowicz, C. Lohmann, B. Weber, A. Ramirez de Molina, J.C. Lacal, S.M. Ametamey, G.K. von Schulthess, T.F. Lüscher, P.A. Kaufmann, A. Buck.
Arterioscler Thromb Vasc Biol. 2006;26:584-9.

Role of endogenous Fas (CD95/Apo-1) ligand in balloon-induced apoptosis. Inflammation and neointima formation.
C.M. Matter, C.E. Chadjichristos, P. Meier, T. von Lukowicz, C. Lohmann, T. Brunner, B.R. Kwak, T.F. Lüscher
Circulation. 2006;113:1879-87.

Degenerative aortic valve stenosis, but not coronary disease, is associated with shorter telemore length in the elderly.
D.J. Kurz, B. Kloeckener-Gruissem, A. Akhemedov, F.R. Eberli, I. Bühler, W. Berger, O. Bertel, T.F. Lüscher.
Arterioscler Thromb Vasc Biol. 2006;26:114-17.

Dark chocolate improves endothelial and platelet function.
F. Hermann, L.E. Spieker, F. Ruschitzka, I. Sudano, M. Hermann, C. Binggeli, T.F. Lüscher, W. Riesen, G. Noll, R. Corti.
Heart. 2006;92:119-20.

Rapamycin, but not FK-506, increases endothelial tissue factor expression: Implications for drug-eluting stent design.
J. Steffel, R.A. Latini, A. Akhmedov, D. Zimmermann, P. Zimmerling, T.F. Lüscher, F.C. Tanner.
Circulation. 2005;112:2002-11.

Glycogen synthase kinase-3 mediates endothelial cell activation by tumor necrosis factor-alpha.
M. Eto, A. Kouroedov, F. Cosentino, T.F. Lüscher.
Circulation. 2005;112:1316-22.

Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization.
S. Windecker, A. Remondino, F.R. Eberli, P. Jüni, L. Räber, P. Wenaweser, M. Togni, M. Billinger, D. Tüller, C. Seiler, M. Roffi, R. Corti, G. Sütsch, W. Maier, T.F. Lüscher, O.M. Hess, M. Egger, B. Meier.
New Engl J Med. 2005;353:653-62.

Coffee blunts mental stress-induced blood pressure increase in habitual but not in nonhabitual coffee drinkers.
I. Sudano, L. Spieker, C. Binggeli, F. Ruschitzka, T.F. Lüscher, G. Noll, R. Corti.
Hypertension. 2005;46:521-6.

Simvastatin improves endothelial function in patients with rheumatoid arthritis.
F. Hermann, A. Forster, R. Chenevard, F. Enseleit, D. Hürlimann, R. Corti, L.E. Spieker, D. Frey, M. Hermann, W. Riesen, M. Neidhardt, B. Michel, J. Hellermann, R. Gay, T.F. Lüscher, S. Gay, G. Noll, F.T. Ruschitzka.
J Amer Coll Cardiol. 2005;45:460-4.

Histamine induces tissue factor: implications for acute coronary syndromes.
J. Steffel, A. Akhmedov, H. Greutert, T.F. Lüscher, F.C. Tanner.
Circulation. 2005;112:341-9.

Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein.
W. Maier, L. Altwegg, R. Corti, S. Gay, M. Hersberger, F.E. Maly, G. Sütsch, M. Roffi, M. Neidhart, F.R. Eberli, F.C. Tanner, S. Gobbi, A. von Eckardtstein, T.F. Lüscher.
Circulation. 2005;111:1355-61.

Selective COX-2 inhibitors and renal injury in salt-sensitive hypertension. (with editorial)
M. Hermann, S. Shaw, E. Kiss, G. Camici, N. Bühler, R. Chenevard, T.F. Lüscher, H.J. Gröne, F. Ruschitzka.
Hypertension. 2005;45:1-5.

Celecoxib decreases endothelial tissue factor expression through inhibition of JNK phosphorylation.
J. Steffel, M. Hermann, H. Greutert, S. Gay, T.F. Lüscher, F. Ruschitzka, F.C. Tanner.
Circulation. 2005;111:1685-9.

Aggravation of focal cerebral ischemia by tissue plasminogen activator is reversed by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor but does not depend on endothelial NO synthase.
E. Kilic, U. Kilic, C.M. Matter, T.F. Lüschher, C.L. Bassetti, D.M. Hermann.
Stroke. 2005;36:332-6.

Systemic inhibition of nitric oxide synthase unmasks neural constraint of maximal myocardial blood flow in humans.
P.A. Kaufmann, O. Rimoldi, T. Gnecchi-Rusconi, T.F. Lüscher, P.G. Camici.
Circulation. 2004;110:1431-6.

Molecular imaging of atherosclerotic plaques using a human antibody against the extra-domain B of fibrinonectin.
C.M. Matter, P.K. Schuler, P. Alessi, P. Meier, R. Ricci, D. Zhang, C. Halin, P. Castellani, L. Zardi, C.K. Hofer, M. Montani, D. Neri, T.F. Lüscher.
Circ Res. 2004;95:1225-33.

JNK2 is required for scavenger receptor-A mediated foam cell formation and atherosgenesis.
R. Ricci, G. Sumara, I.J. Sumara, I. Rosenberg, M. Kurrer, A. Akhmedov, M. Hersberger, F.R. Eberli, E.F. Wagner, C.M. Matter, T.F. Lüscher.
Science. 2004;306:1558-61.

Selective inhibition of PKC beta II as therapeutic approach to treatment of endothelial dysfunction during acute hyperglycemia. (with editorial)
Kouroedov, F. Cosentino, M. Eto, H. Joch, M. Vople, T.F. Lüscher.
Circulation. 2004;110:91-6.

Deletion of p66shc gene protects against age-related endothelial dysfunction.
P. Francia, C. delli Gatti, M. Bachschmid, I. Martin-Padura, C. Savoia, E. Migliaccio, P.G. Pelicci, M. Schiavoni, T.F. Lüscher, M. Volpe, F. Cosentino.
Circulation. 2004;110:2889-95.

Long-term Effects of darusentan on LV remodeling and clinical outcomes - The Endothelin A Receptor Antagonist Trial in Heart Failure (EARTH).
I.S. Anand, J. McMurray, J.N. Cohn, M.A. Konstam, T. Notter, K. Quitzau, F. Ruschitzka, T.F. Lüscher on behalf of the EARTH investigators.
Lancet. 2004;364:347-54.

Different cell cycle regulation of vascular smooth muscle in genetic hypertension.
F. Tanner, H. Greutert, C. Barandier, K. Frischknecht, T.F. Lüscher.
Hypertension. 2003;42:184-8.

Differential effects of selective cyclooxygenase-2 inhibition on endothelial function in salt-induced hypertension.
M. Hermann, G. Camici, A. Fratton, D. Hürlimann, M. Fiedler, J. Thierry, M. Neidhart, R.E. Gay, S. Gay, T.F. Lüscher, F.T. Ruschitzka.
Circulation. 2003;108:2308-11.

Satins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells.
F. Mulhaupt, C.M. Matter, B.R. Kwak, G. Pelli, N.R. Veillard, F. Burger, P. Graber, T.F. Lüscher, F. Mach.
Cardiovasc Res. 2003;59:755-66.

Characterization of dysfunctional myocardium by positron emission tomography and magnetic resonance: relation to functional outcome after revascularization.
P.R. Knuesel, D. Nanz, C. Wyss, M. Buechi, G.K. von Schulthess, T.F. Lüscher, J. Schwitter.
Circulation. 2003;108:1095-100.

Fibroblast growth factor-2, but not vascular endothelial growth factor, upregulates telomerase activity in human endothelial cells.
D.J. Kurz, Y. Hong, E. Trivier, H.L. Huang, S. Decary, G.H. Zang, T.F. Lüscher, J.D. Erusalimsky.
Arterioscler Thromb Vasc Biol. 2003;23:748-54.

Dysfunctional Baroreflex Regulation of Sympathetic Nerve Activity in Patients with Vasovagal Syncope.
M. Béchir, C. Binggeli, R. Corti, R. Chenevard, F. Ruschitzka, T.F. Lüscher, G. Noll.
Circulation. 2003;107:1620-5.

Statins enhance post-ischemic hyperemia in the skin circulation of hypercholesterolemic patients: a monitoring test of endothelial dysfunction for clinical practice?
C. Binggeli, L.E. Spieker, R. Corti, I. Sudano, V. Stojanovic, D. Hayoz, T.F. Lüscher, G. Noll.
J Amer Coll Cardiol. 2003;42:71-7.

Erythropoetin-induced excessive erythrocytosis activates the tissue endothelin system in mice.
T. Quaschning, F. Ruschitzka, T. Stallmach, S. Shaw, H. Morawietz, W. Goettsch, M. Hermann, T. Slowinski, F. Theuring, B. Hocher, T.F. Lüscher, M. Gassmann.
FASEB J. 2003;17:259-61.

Selective COX-2 inhibition improves endothelial function in coronary artery disease.
R. Chenevard, D. Hürlimann, M. Béchir, F. Enseleit, L. Spieker, M. Hermann, W. Riesen, S. Gay, R. Gay, M. Neidhart, T.F. Lüscher, G. Noll, F. Ruschitzka.
Circulation. 2003;107:405-9.

High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species.
F. Cosentino, M. Eto, P. de Paolis, B. van der Loo, M. Bachschmid, V. Ulrich, A. Kouroedov, C. delle Gatti, M. Volpe, T.F. Lüscher.
Circulation. 2003;107:1017-1023.

Effects of nifedipine and cerivastatin on coronary endothelial function. The ENCORE-1 trial.
T.F. Lüscher on behalf of the ENCORE investigators.
Circulation. 2003;107:422-8.

Hemodynamic and neurohumoral effects of selective endothelin A (ETA) receptor blockade in chronic heart failure: the heart failure ETA receptor blockade trial (HEAT).
T.F. Lüscher, F. Enseleit, R. Pacher, V. Mitrovic, M.R. Schulze, R. Willenbrock, R. Dietz, V. Rousson, D. Hürlimann, S. Philipp, T. Notter, G. Noll, F. Ruschitzka.
Circulation. 2002;106:2666-72.

Coffee acutely increases sympathetic nerve activity and blood pressure independently of caffeine content: role of habitual vs. non-habitual drinking.
R. Corti, C. Binggeli, I. Sudano, L. Spieker, E. Hänseler, F. Ruschitzka, W.F. Chaplin, T.F. Lüscher, Georg Noll.
Circulation. 2002;106:2935-40.

Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis.
D. Hürlimann, A. Forster, G. Noll, F. Enseleit, R. Chenevard, O. Distler, M. Béchir, L.E. Spieker, M. Neidhart, B.A. Michel, R.E. Gay, T.F. Lüscher, S. Gay, F. Ruschitzka.
Circulation. 2002;106:2184-7.

Mental stress induces prolonged endothelial dysfunction via endothelin A receptors.
L. Spieker, D. Hürlimann, F. Ruschitzka, R. Corti, F. Enseleit, S. Shaw, D. Hayoz, J.E. Deanfield, T.F. Lüscher, G. Noll.
Circulation. 2002;105:2817-20.

Electrocardiographically gated multi-detector row CT for assessement of valvular morphology and calcification in aortic stenosis.
J.K. Willmann, D. Weishaupt, M. Lachat, R. Kobza, J.E. Roos, B. Seifert, T.F. Lüscher, B. Marincek, P.R. Hilfiker.
Radiology. 2002;225:120-8.

Statin prevents tissue factor expression in human endothelial cells: role of Rho/Rho-kinase and Akt pathways.
M. Eto, T. Kozai, F. Cosentino, H. Joch, T.F Lüscher.
Circulation. 2002;15:1765-59.

Cardiovascular aging is associated with vitamin E increase.
B. van der Loo, R. Labugger, C.P. Aebischer, J.N. Skepper, M. Bachschmid, V. Spitzer, J. Kilo, L. Altwegg, V. Ullrich, T.F. Lüscher.
Circulation. 2002;105:1635-8.

Reconstituted high density lipoproteins normalize endothelial function in hypercholesterinemia.
L. Spieker, D. Hürlimann, F. Enseleit, T.F. Lüscher, G. Noll.
Circulation. 2002;105:1399-402.

Effects of chronic calcium channel blockade on muscle sympathetic nerve activity in hypertension: the Vera Trial comparing nifedipine, amlodipine and verapamil.
C. Binggeli, R. Corti, I. Sudano, T.F. Lüscher, G. Noll.
Hypertension. 2002;39:892-6.

Nitric-oxide-mediated relaxations in salt-induced hypertension: effect of chronic ß1 selective receptor blockade.
F. Cosentino, S. Bonetti, R. Rehorik, M. Eto, G. Werner-Felmayer, M. Volpe, T.F. Lüscher.
J Hypertension. 2002;20:421-8.

Chronic ETA receptor blockade prevents endothelial dysfunction of the microcirculation in apolipoprotein E-deficient mice.
L. D’Uscio, M. Barton, S. Shaw, C.C. Haudenschild, T.F. Lüscher.
Cardiovasc Res. 2002;53:487-95.

Felodipine inhibits human smooth muscle cell growth by blockade of nuclear translocation of p42/44 mitogen-activated protein kinase.
Z. Yang, A. Madinova, T. Kozai, H. Joch, U. Aebi, T.F. Lüscher
Cardiovasc Res. 2002;53:227-31.

Thrombin suppresses endothelial nitric oxide synthase and upregulates endothelin-converting enzyme-1 expression by distinct pathways: role of Rho/ROCK and mitogen-activated protein kinase.
M. Eto, C. Barandier, L. Rathgeb, T. Kozai, H. Joch, Z. Yang, T.F. Lüscher.
Circ Res. 2001;89:583-90.

Predictors of long-term survival after valve replacement for chronic aortic regurgitation: is M-mode echocardiography sufficient?
R. Corti, C. Binggeli, M. Turina, R. Jenni, T.F. Lüscher, J. Turina.
Eur Heart J. 2001;22:866-73.

ETA receptor antagonism prevents vascular dysfunction in 11ß-hydroxysteroid dehydrogenase deficient hypertension. Role of Nitric Oxide.
F. Ruschitzka, T. Quaschning, G. Noll , A. de Gottardi, M. Rossier, F. Enseleit, T.F. Lüscher, S. Shaw.
Circulation. 2001;103:3129-35.

Vasopeptidase inhibition restores renovascular endothelial dysfunction in salt-induced hypertension.
T. Quaschning, L.V. d'Uscio, S. Shaw, H.J. Gröne, F. T. Ruschitzka, T.F. Lüscher.
J Amer Soc Nephrol. 2001;12:2280-7.

Vasopeptidase inhibition exhibits endothelial protection in salt-induced hypertension.
T. Quaschning, L.V. d'Uscio, S. Shaw, T.F. Lüscher.
Hypertension. 2001;37:1108-13.

Assessement of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography.
J. Schwitter, D. Nanz, S. Kneifel, K. Bertschinger, M. Büchi, P.R. Knüsel, B. Marincek, T.F. Lüscher, G.K. von Schulthess.
Circulation. 2001;103:2230-5.

Aldosterone receptor antagonism normalizes vascular function in liquorice-induced hypertension.
T. Quaschning, F.T. Ruschitzka, S. Shaw, T.F. Lüscher
Hypertension. 2001;37:801-5.

Reactive oxygen species mediate endothelium-dependent relaxations in tetrahydrobiopterin deficient mice.
F. Cosentino, J.E. Barker, M.P. Brand, S.J. Heales, E.R. Werner, J.R. Tippins, N. West, K.M. Channon, M. Volpe, T.F. Lüscher.
Arterioscl Thromb Vasc Biol. 2001;21:496-502.

Vasopeptidase inhibition prevents endothelial dysfunction of resistance arteries in salt-sensitive hypertension in comparison with single ACE-inhibition.
L. d’Uscio, T. Quaschning, M. Barton, D. Heublein, J.C. Burnett Jr., T.F. Lüscher.
Hypertension. 2001;37:28-33.

HMG-CoA reductase inhibition improves endothelial cell function and inhibits smooth muscle cell proliferation in human saphenous veins.
Z. Yang, T. Kozai, B. van der Loo, H. Veswambharan, M. Lachat, M.I. Turina, T. Malinski, T.F. Lüscher.
J Amer Coll Cardiol. 2000;36:1691-7.

Enhanced peroxynitrite formation is associated with vascular aging.
B. van der Loo, R. Labugger, J.N. Skepper, M. Bachschmid, J. Kilo, J.M. Powell, M. Palacios-Callender, J. D. Erusalimsky, T. Quaschning, T. Malinski, D. Gygi, V. Ullrich, T.F. Lüscher.
J Exp Med. 2000;192:1731-43.

Dysfunctional renal nitric oxide synthase as a determinant of salt- sensitive hypertension: mechanisms of renal artery endothelial dysfunction and role of endothelin for vascular hypertrophy and Glomerulosclerosis.
M. Barton, I. Vos , S. Shaw, P. Boer, L.V. d'Uscio, H.J. Grone, T.J. Rabelink, T. Lattmann, P. Moreau, T.F. Lüscher.
J Am Soc Nephrol. 2000;11:835-45.

Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoetin
F. Ruschitzka, R. Wenger, T. Stallmach, T. Quaschning, C. de Vit, R. Labugger, M. Kelm, G. Noll, T. Rühlicke, S. Shaw, R. Lindberg, B. Rodenwald, H. Lutz, C. Bauer, T.F. Lüscher, M. Gassmann.
Proc Natl Acad Sci USA. 2000;97:11609-13.

Tissue endothelin-converting enzyme activity correlates with cardiovascular risk factors in coronary artery disease.
F. Ruschitzka, U. Moehrlein, T. Quaschning, M. Lachat, G. Noll, S. Shaw, Z. Yang, D. Teubser, T. Subkowski, M.I. Turina, T.F. Lüscher.
Circulation. 2000;102:1086-92.

Coronary heart disease in smokers: vitamin C restores microcirculatory function.
P.A. Kaufmann, T. Gnecchi-Ruscone, M. di Terlizzi, K.P. Schäfers, T.F. Lüscher, P.G. Camici.
Circulation. 2000;102:1233-8.

Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia.
P.A. Kaufmann, T. Gnecchi-Ruscone, K.P. Schäfers, T.F. Lüscher, P.G. Camici.
J Amer Coll Cardiol. 2000;36:103-9.

Nitric oxide modulates expression of cell cycle regulatory prteins: a cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation.
F.C. Tanner, P. Meier, H. Greutert, C. Champion, E.G. Nabel, T.F. Lüscher.
Circulation. 2000;101:1982-9.

Baroreceptor dysfunction induced by nitric oxide synthase inhibition.
L.E. Spieker, R. Corti, C. Binggeli, T.F. Lüscher, G. Noll.
J Amer Coll Cardiol. 2000;36:213-18.

Acute hemodynamic and neurohumoral effects of selective ETA receptor blockade in patients with congestive heart failure.
L.E. Spieker, V. Mitrovic, G. Noll, R. Pacher, M.R. Schulze, J. Muntwyler, C. Schalcher, W. Kiowski, T.F. Lüscher on behalf of the ET 003 investigators.
J Amer Coll Cardiol. 2000;35:1745-52.

Acute heart transplant rejection due to St. John’s wort.
F. Ruschitzka, P.J. Meier, M. Turina, T.F. Lüscher, G. Noll.
Lancet. 2000;355:548-9.

Magnetic resonance-based assessement of global flow and flow reserve and ist relation to left ventricular function parameters: a comparison with positron emission tomography.
J. Schwitter, G.K. von Schulthess, S. Kneifel, T. deMarco, M. Ciopor Jörg, H. Arheden, S. Rühm, K. Stumpe, A. Buck, T.F. Lüscher, W.W. Parmley, C.B. Higgins.
Circulation. 2000;101:2696-702.

Obestiy is associated with tissue-specific activation of renal angiotensin converting enzyme in vivo. Evidence for a regulatory role of endothelin.
M. Barton, R. Carmona, H. Morawitz, L.V. d1Uscio, W. Goettsch, H. Hillen, C. Haudenschild, J.E. Krieger, K. Münter, T. Lattmann, T.F. Lüscher, S. Shaw.
Hypertension. 2000;35(1 Pt 2):329-36.

Effects of atrial pacing on arterial and coronary sinus endothelin-1 levels in syndrome X.
G.A. Lanza, T.F. Lüscher, V. Pasceri, S.G. Shaw, A. Buffon, A.S. Montenero, F. Crea, A. Maseri.
Am J Cardiol. 1999;84:1187-91.

Connective tissue growth factor induces apoptosis in human breast cancer cell line MCF-7.
K. Hishikawa, B.S. Oemar, F.C. Tanner, T. Nakaki, T.F. Lüscher, T. Fujii.
J Biochem Chem. 1999;274:37461-6.

Endothelin-1 markedly potentiates human smooth muscle cell growth to PDGF: effects of ETA and ETB recepotor blockade.
Z. Yang, N. Krasnici, T.F. Lüscher.
Circulation. 1999;100:5-8.

Overexpression of connective tissue growth factor gene induces apoptosis in human aortic smooth muscle cells.
K. Hishikawa, B.S. Oemar, F.C. Tanner, T. Nakaki, T. Fujii, T.F. Lüscher.
Circulation. 1999;100:2108-12.

Effect of Ox-LDL on endothelium-dependent response in pig ciliary artery: prevention by an ETA-antagonist.
P. Zhu, E.S. Dettmann, T.J. Resink, T.F. Lüscher, A.J. Flammer, I.O. Haefliger.
Invest Ophthalmol Vis Sci. 1999;40:1015-20.

Endothelial dysfunction in acute renal failure: role of endothelin-1.
F. Ruschitzka, S. Shaw, G. Noll, M. Barton, T.F. Lüscher.
J Amer Soc Nephrol. 1999;10:953-62.

Accuracy of a new wrist cuff oscillometric blood pressure device: comparisons with intra-arterial and mercury manometer measurements.
S. Watson, R.R. Wenzel, C. di Matteo, B. Meier, T.F. Lüscher.
Am J Hypertension. 1999;11:1469-74.

I1-Imidazoline agonist moxonidine decreases sympathetic nerve activity and blood pressure in hypertension.
R.R. Wenzel, L. Spieker, S. Qui, S. Shaw, B. Meier, T.F. Lüscher, G. Noll.
Hypertension. 1998;32:1022-7.

Endothelial vasoconstrictor prostanoids, vascular reactivity, and acute renal failure.
F. Ruschitzka, S. Shaw, G. Noll, M. Barton, E. Schulz, G.A. Müller, T.F. Lüscher.
Kidney Int. 1998;67:S199-201.

Nitrate induced coronary vasodilatation: differential effects of sublingual application by capsule or spray.
M. Pfister, C. Seiler, M. Fleisch, H. Göbel, T. F. Lüscher, B. Meier.
Heart. 1998;80:365-9.

Endothelin-1 induces vasodilation in human skin by nociceptor fibres and release of nitric oxide.
R.R. Wenzel, S. Zbinden, G. Noll, B. Meier, T.F. Lüscher.
Br J Clin Pharmacol. 1998;45:441-6.

Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis.
B.S. Oemar, M.R. Tschudi, N. Godoy, V. Brovkovich, T. Malinski, T.F. Lüscher.
Circulation. 1998;97:2494-8.

Midazolam premedication improves tolerance of transesophageal echocardiography.
B.C. Aeschbacher, M. Portner, M. Fluri, B. Meier, T.F. Lüscher.
Am J Cardiol. 1998;81:1022-6.

ETA receptor blockade prevents increased tissue endothelin-1, vascular hypertrophy, and endothelial dysfunction in salt-sensitive hypertension.
M. Barton, L. d’Uscio, S. Shaw, P. Meyer, P. Moreau, T.F. Lüscher.
Hypertension. 1998;31:499-504.

Angiotensin II and insulin induce growth of ciliary artery smooth muscle: effects of AT1/AT2 antagonists.
R.K. Dubey, A.J. Flammer, T.F. Lüscher.
Invest Ophthal Vis Sci. 1998;39:2067-75.

Hemodynamic and coronary effects of the endothelin antagonists bosentan in patients with coronary artery disease.
R.R. Wenzel, M. Fleisch, S. Shaw, G. Noll, U. Kaufmann, R. Schmitt, C.R. Jones, M. Clozel, B. Meier, T.F. Lüscher.
Circulation. 1998;98:2235-40.

Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice.
M. Barton, C.C. Haudenschild, L. d’Uscio, S. Shaw, K. Münter, T.F. Lüscher.
Proc Natl Acad Sci USA. 1998;95:14367-72.

Felodipine inhibits free-radical production by cytokines and glucose in human smooth muscle cells.
K. Hishikawa, T.F. Lüscher.
Hypertension. 1998;32:1011-15.

Effect of chronic nitric oxide deficiency on angiotensin II-induced hypertrophy of rat basilar artery.
P. Moreau, H. Takase, L. d’Uscio, T.F. Lüscher.
Stroke. 1998;29:1031-6.

Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats.
F. Cosentino, S. Patton, L. d’Uscio, E.R. Werner, G. Werner-Felmayer, P. Moreau, T. Malinski, T.F. Lüscher.
J Clin Invest. 1998;101:1530-7.

Different proliferative properties of smooth muscle cells of human arteral and venous bypass vessels: role of PDGF receptors, mitogen-activated kinase, and cyclin-dependent kinase inhibitors.
Z. Yang, B.S. Oemar, T. Carrel, B. Kipfer, F. Julmy, T.F. Lüscher.
Circulation. 1998;97:181-7.

Structure and reactivity of small arteries in aging.
P. Moreau, L. d’Uscio, T.F. Lüscher.
Cardiovasc Res. 1998;37:247-53.

Alterations to the nitric oxide pathway in the spontaneously hypertensive rat.
E. Nava, A.L. Farré, C. Moreno, S. Casado, P. Moreau, F. Cosentino, T.F. Lüscher.
J Hypertension. 1998;16:609-15.

Losartan but not verapamil inhibits angiotensin II-induced tissue endothelin-1 increase: role of blood pressure and endothelial function.
L. d’Uscio, S. Shaw, M. Barton, T.F. Lüscher.
Hypertension. 1998;31:1305-10.

Pulsatile stretch stimulates superoxide production in human aortic endothelial cells.
K. Hishikawa, T.F. Lüscher.
Circulation. 1997;96:3610-16.

Role of nitric oxide in the regulation of the mechanical properties of peripheral conduit arteries in humans.
R. Ioannides, V. Richard, W.E. Haefeli, A. Benoist, L. Linder, T.F. Lüscher,
C. Thuillez.
Hypertension. 1997;30:1465-70.

Relaxation by bradykinin in porcine ciliary artery: role of nitric oxide and K+-channels.
P. Zhu, J.L. Bény, A.J. Flammer, T.F. Lüscher, I.O. Häfliger.
Invest Ophthal Vis Sci. 1997;38:1761-7.

Pulsatile stretch stimulates superoxide production and activates nuclear factor NFB in human coronary smooth muscle.
K. Hishikawa, B.S. Oemar, Z. Yang, T.F. Lüscher.
Circ Res. 1997;81:797-803.

Differential activation of cardiac and peripheral sympathetic nervous system by nifedipine: role of pharmacokinetics.
R.R. Wenzel, G. Allegranza, C. Binggeli, S. Shaw, P. Weidmann, T.F. Lüscher, G. Noll.
J Amer Coll Cardiol. 1997;29:1607-14.

Angiotensin II increases tissue endothelin and induces vascular hypertrophy in vivo: reversal by ETA-receptor antagonist.
P. Moreau, L.V. d'Uscio, S. Shaw, H. Takase, M. Barton, T.F. Lüscher.
Circulation. 1997;96:1593-97.

High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. (Brief Rapid Communication)
F. Cosentino, K. Hishikawa, Z.S. Katusic, T.F. Lüscher.
Circulation. 1997;96:25-28.

Anatomic heterogeneity of vascular aging: role of nitric oxide and endothelin.
M. Barton, L. d'Uschio, S. Shaw, P. Moreau, T.F. Lüscher.
Hypertension. 1997;30:817-24.

Quinaprilat induces arterial vasodilation mediated by nitric oxide in humans.
W.E. Haefeli, L. Linder, T.F. Lüscher.
Hypertension. 1997;30:912-17.

Structure and function of small arteries in salt-induced hypertension: effects of chronic ETA-receptor blockade.
L.V. d'Uschio, M. Barton, S. Shaw, P. Moreau, T.F. Lüscher.
Hypertension. 1997;30:905-11.

Effects of chronic ETA-receptor blockade in angiotensin II-induced hypertension.
L.V. d'Uschio, P. Moreau, S. Shaw, H. Takase, M. Barton, T.F. Lüscher.
Hypertension. 1997;29:435-41.

Bi-modal effects of angiotensin II on migration of human and rat smooth muscle cells: direct stimulation and indirect inhibition via transforming growth factor beta-1.
G. Liu, E. Espinosa, B.S. Oemar, T.F. Lüscher.
Arterioscl Thromb Vasc Biol. 1997;17:1251-7.

Differential effects of captopril and nitrates on muscle sympathetic nerve activity in volunteers.
G. Noll, R.R. Wenzel, S. de Marti, S. Shaw, T.F. Lüscher.
Circulation. 1997;95:2286-92.

Different effects of thrombin receptor activation on endothelium and smooth muscle cells of human coronary bypass vessels: implications for venous bypass graft failure.
Z. Yang, F. Ruschitzka, T.J. Rabelink, F. Julmy, G. Noll, H. Dolesal, U. Althaus, T.F. Lüscher.
Circulation. 1997;95:1870-6.

Human connective tissue growth factor is expressed in advanced atherosclerotic lesions.
B.S. Oemar, A. Werner, J.M. Garnier, Do dai-Do, N. Godoy, M. Nauck, W. März, J. Rupp, M. Pech, T.F. Lüscher.
Circulation. 1997;95:831-9.

Blood pressure and vascular effects of endothelin blockade in chronic nitric oxide-deficient hypertension.
P. Moreau, H. Takase, C.F. Küng, S. Shaw, T.F. Lüscher.
Hypertension. 1997;29:763-9.

Tetrahydrobiopterin restores endothelial function in hypercholesteremia.
E. Stroes, J. Kastelein, F. Cosentino, W. Erkelens, R. Wever, H. Koomans, T. F. Lüscher, T. Rabelink.
J Clin Invest. 1997;99:41-6.

Cyclosporin A increases nitric oxide activity in vivo.
E.S.G. Stroes, T.F. Lüscher, F.G. de Groot, H.A. Koomans, T.J. Rabelink.
Hypertension. 1997;29:570-5.

Endothelium-derived vasoconstrictor prostanoids modulate contractions to acetylcholine and angiotensin II in mesenteric resistance arteries of ren-2 transgenic rats.
G. Noll, M. Lang, M.R. Tschudi, D. Ganten, T.F. Lüscher.
Am J Physiol. 1997;272 (1 Pt 2):H493-500.

Effect of dipyridamole on vascular responses of porcine ciliary arteries.
P. Meyer, A.J. Flammer, T.F. Lüscher.
Curr Eye Res. 1996;15:387-93.

Percutaneous transluminal coronary angioplasty through 5 french diagnostic catheters.
Garachamani, U. Kaufmann, M. Fleisch, B.J. Meyer, T.F. Lüscher, B. Meier.
J Invas Cardiol. 1996;6:433-7.

Effect of pre-treatment with transdermal glyceryl trinitrate in myocardial ischemia during cornary angioplasty.
S. Ramamurthy, V. Mehan, U. Kaufmann, V. Verin, T.F. Lüscher, B. Meier.
Heart. 1996;6:471-6.

Low-dose heparin for routine coronary angioplasty and stenting.
J. Vainer, M. Fleisch, P. Gunnes, S. Ramamurthy, A. Grachemani, U.P. Kaufmann, B.J. Meyer, T.F. Lüscher, B. Meier.
Am J Cardiol. 1996;78:964-6.

Effect of age on kinetics of nitric oxide release in rat aorta and pulmonary artery. (Rapid Publication)
M.R. Tschudi, M. Barton, F. Cosentino, P. Moreau, G. Noll, T. Malinski, T.F. Lüscher.
J Clin Invest. 1996;98:899-905.

17ß-oestradiol inhibits proliferation and migration of human vascular smooth muscle cells: similar effects in cells from post-menopausal females and in males.
Do dai-Do, E. Espinosa, G. Liu, T.J. Rabelink, F. Julmy, Z. Yang, F. Mahler, T.F. Lüscher.
Cardiovasc Res. 1996;92:980-5.

Effect of endothelin antagonists on the responses to prostanoid endothelium-derived contracting factor.
P. Moreau, H. Takase, T.F. Lüscher.
Brit J Pharmacol. 1996;118:1429-32.

Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease: the TREND (Trial on reversing endothelial dysfunction) study.
J.G.B. Mancini, G.C. Henry, C. Macaya, B.J. O'Neill, A.L. Pucillo, R.G. Carere, T.J. Wargovich, H. Mudra, T.F. Lüscher, M.I. Klibaner, H.E. Haber, A.C.G. Uprichard, C.J. Pepine, B. Pitt.
Circulation. 1996;94:258-65.

Endothelin-1-induced release of thromboxane A2 increases the vasoconstrictor effect of endothelin-1 in postischemic reperfused rat hearts.
C.E. Zaugg, P. Zhu, P. Hornstein, D. Simper, T.F. Lüscher, P.R. Allegrini, P.T. Buser.
Circulation. 1996;94:742-7.

Endothelin and calcium antagonists in the skin microcirculation of patients with coronary artery disease.
R.R. Wenzel, N. Duthiers, G. Noll, J. Bucher, U. Kaufmann, T.F. Lüscher.
Circulation. 1996;94:316-22.

Increased activation of sympathetic nervous system and endothelin by mental stress in normotensive offspring of hypertensive parents. (Rapid publication)
G. Noll, R.R. Wenzel, M. Schneider, V. Oesch, C. Binggeli, S. Shaw, P. Weidmann, T.F. Lüscher.
Circulation. 1996;93:866-9.

Antihypertensive therapy prevents endothelial dysfunction in chronic nitric oxide deficiency: effect of Verapamil and Trandolapril.
H. Takase, P. Moreau, L. d'Uscio, T.F. Lüscher.
Hypertension. 1996;27:25-31.

Direct in situ measurement of nitric oxide in mesenteric resistance arteries: increased decomposition by superoxide in hypertension.
M.R. Tschudi, S. Mesaros, T.F. Lüscher, T. Malinski.
Hypertension. 1996;27:32-5.

Expression of nitric oxide synthase isoforms in the thyroid gland: evidence for a role of nitric oxide in vascular control during goiter formation.
I.M. Colin, E. Nava, D. Toussaint, D.M. Maiter, M.F. van Denhove, T.F. Lüscher, J.M. Ketelslegers, J.F. Denef, L. Jameson.
Endocrinology. 1995;136:5283-90.

Structure and function of the rat basilar artery during chronic nitric oxide synthase inhibition.
P. Moreau, H. Takase, C.F. Küng, M.M. van Rooijen, T. Schaffner, T.F. Lüscher.
Stroke. 1995;26:1922-9.

L-NAME hypertension alters endothelial and smooth muscle function in rat aorta: prevention by trandolapril and verapamil.
C.F. Küng, P. Moreau, H. Takase, T.F. Lüscher.
Hypertension. 1995;26:744-51.

Role of basal and stimulated release of nitric oxide in the regulation of radial artery caliber in humans.
R. Joannides, V. Richard, W.E. Haefeli, L. Linder, T.F. Lüscher, C. Thuillez.
Hypertension. 1995;26:327-31.

Effect of aging and hypertension on contractility of resistance arteries: modulation by endothelial factors.
M.G. Lang, G. Noll, T.F. Lüscher.
Am J Physiol. 1995;269:H837-44.

ETA and ETB receptors mediate contraction to endothelin-1 in renal artery of aging spontaneously hypertensive rats: effects of FR139317 and bosentan.
B. Seo, T.F. Lüscher.
Hypertension. 1995;25:501-6.

Endothelin receptor subtypes in small arteries: studies with FR139317 and bosentan.
H. Takase, P. Moreau, T.F. Lüscher.
Hypertension. 1995;25:739-43.

Increased activity of constitutive nitric oxide synthase in cardiac endothelium in spontaneous hypertension. (Brief communication)
E. Nava, G. Noll, T.F. Lüscher.
Circulation. 1995;91:2310-3.

Local action of the renin angiotensin system in the porcine ophthalmic circulation: effects of ACE-Inhibitors and angiotensin receptor antagonists.
P. Meyer, A.J. Flammer, T.F. Lüscher.
Invest Ophthalmol Vis Sci. 1995;36:555-62.

Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell.
R.K. Dubey, E.K. Jackson, T.F. Lüscher.
J Clin Invest. 1995;96:141-9.

Age and hypertension differently affect coronary contractions to endothelin-1, serotonin and angiotensins.
M.R. Tschudi, T.F. Lüscher.
Circulation. 1995;91:2415-22.

Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.
R. Joannides, W.E. Häfeli, L. Linder, V. Richard, H. Bakkali, C. Thuillez, T.F. Lüscher
Circulation. 1995;91:1314-9.

Different mechanisms of endothelial dysfunction with aging and hypertension in rat aorta.
C.F. Küng, T.F. Lüscher.
Hypertension. 1995;25:194-200.

Endothelin-1 in pulmonary hypertension associated with high altitude exposure.
S. Goerre, M. Wenk, P. Bärtsch, T.F. Lüscher, F. Niroomand, E. Hohenhaus, O. Oelz, W.H. Reinhart.
Circulation. 1995;91:359-64.

Treatment of acute pulmonary hypertension with inhaled nitric oxide.
M. Tönz, L.K. von Segesser, J. Schilling, T.F. Lüscher, G. Noll, B. Leskosek, M.I. Turina
Ann Thorac Surg. 1994;58:1031-5.

Endothelin Receptor Antagonists Inhibit Endothelin in Human Skin Microcirculation. (Rapid Communication)
R. R. Wenzel, G. Noll, T.F. Lüscher.
Hypertension. 1994;23:581-6.

Alterations in coronary artery vascular reactivity of hypertensive ren-2 transgenic rats.
M.R. Tschudi, G. Noll, U. Arnet, D. Novosel, D. Ganten, T.F. Lüscher.
Circulation. 1994;89:2780-6.

Antihypertensive therapy augments endothelium-dependent relaxations in coronary arteries of spontaneously hypertensive rats.
M.R. Tschudi, L. Criscione, D. Novosel, K. Pfeiffer, T.F. Lüscher.
Circulation. 1994;89:2212-8.

Thrombin-induced endothelium-dependent inhibition and direct activation of platelet-vessel wall interaction.
Z. Yang, U. Arnet, E. Bauer, L von Segesser, R. Siebenmann, M. Turina, T.F. Lüscher.
Circulation. 1994;89:2266-72.

Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. (Brief communication)
B. Seo, B.S. Oemar, R. Siebenmann, L. von Segesser, T.F. Lüscher.
Circulation. 1994;89:1203-8.

Endothelium-dependent regulation of the ophthalmic microcirculation in the perfused porcine eye: role of nitric oxide and endothelins.
P. Meyer, A.J. Flammer, T.F. Lüscher.
Invest Ophthal Vis Sci. 1993;34:3614-21.

Calcium antagonists differently inhibit proliferation of human coronary smooth muscle cells in response to pulsatile stretch and platelet-derived growth factor. (Brief communication)
Z. Yang, G. Noll, T.F. Lüscher.
Circulation. 1993;88:832-6.

The influence of the endothelial surface on flow in vitro.
W.H. Reinhart, C.M. Boulanger, T.F. Lüscher, A. Haeberli, P.W. Straub.
Am J Physiol. 1993;265:H523-9.

Local anesthetic drugs reduce endothelium-dependent relaxations of porcine ciliary arteries.
P. Meyer, A.J. Flammer, T.F. Lüscher.
Invest Ophthalmol Vis Sci. 1993;34:2730-6.

Heterogeneity of endothelium-dependent regulation in ophthalmic and ciliary arteries.
I.O. Haefliger, A.J. Flammer, T.F. Lüscher.
Invest Ophthal Vis Sci. 1993;34:1722-30.

Endothelium-derived contracting factors in resistance arteries of prehypertensive rats.
M. Jameson, D. Fu-Xiang, T.F. Lüscher, J. Skopec, A. Diederich, D. Diederich.
Hypertension. 1993;21:280-8.

Nitric oxide and endothelin-1 are important regulators of human ophthalmic artery.
I.O. Häfliger, A.J. Flammer, T.F. Lüscher.
Invest Ophthal Vis Sci. 1992;33:2340-3.

Implications of pulsatile stretsch on growth of saphenous vein and mammary artery smooth muscle.
H.G. Predel, Z. Yang, L. von Segesser, M. Turina, F.R. Bühler, T.F. Lüscher.
Lancet. 1992;340:878-9.

Different effects of aggregating platelets in the right gastroepiploic and internal mammary artery: implications for coronary artery grafting.
X.N. Li, P. Stulz, R.B. Siebenmann, Z. Yang, T.F. Lüscher.
J Thorac Cardiovasc Surg. 1992;104:1294-302.

Intraluminal pressure modulates vascular contractility of perfused mesenteric resistance arteries: altered response in hypertension.
M.A. Thiel, A.H. Bock, F.R. Bühler, T.F. Lüscher.
Am J Hypertension. 1992;5:542-7.

Nitric oxide and endothelin-1 are important regulators of human ophthalmic artery.
I.O. Haefliger, A.J. Flammer, T.F. Lüscher.
Invest Ophthal Vis Sci. 1992;33:2340-3.

Similar endothelium-dependent relaxation, but enhanced contractility of the right gastroepiploic artery as compared to internal mammary artery.
Z. Yang, R. Siebenmann, M. Studer, L. Egloff, T.F. Lüscher.
J Thorac Cardiovasc Surg. 1992;104:459-64.

Oxidized low-density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium.
C.M. Boulanger, F.C. Tanner, A.W.A. Hahn, A. Werner, T.F. Lüscher.
Circ Res. 1992;70:1191-7.

Endothelin stimulated by angiotensin II augments vascular contractility of hypertensive resistance arteries.
Y. Dohi, A.W.A. Hahn, C.M. Boulanger, F.R. Bühler, T.F. Lüscher.
Hypertension. 1992;19:131-7.

Chronic cyclosporine therapy impairs endothelium-dependent relaxations in the renal artery of the rat.
D. Diederich, Z. Yang, T.F. Lüscher.
J Am Soc Nephrol. 1992;2:1291-7.

Endothelin in hypertensive resistance arteries: intraluminal and extraluminal dysfunction.
Y. Dohi, T.F. Lüscher.
Hypertension. 1991;18:543-9.

Effect of aging and hypertension on endothelial function of rat coronary arteries.
M.R. Tschudi, L. Criscione, T.F. Lüscher.
J Hypertension. 1991;9(Suppl. 6):S164-5.

Renovascular hypertension impairs formation of endothelium-derived relaxing factors and sensitivity to endothelin-1 in resistance arteries.
Y. Dohi, L. Criscione, T.F. Lüscher.
Br J Pharmacol. 1991;104:349-54.

Endothelin-1 in perfused hypertensive resistance arteries: different intra- and extraluminal dysfunction.
Y. Dohi, T.F. Lüscher.
Hypertension. 1991;18:543-9.

Different potency of endothelium-derived relaxing factors against thromboxane, endothelin and potassium chloride in porcine intramyocardial resistance arteries.
G. Noll, F.R. Bühler, T.F. Lüscher.
J Cardiovasc Pharmacol. 1991;18:120-6.

Oxidized low-density lipoproteins inhibit relaxations of porcine coronary arteries: role of scavenger receptor and endothelium-derived nitric oxide.
F.C. Tanner, G. Noll, C.M. Boulanger, T.F. Lüscher.
Circulation. 1991;83:2012-20.

Nitrovasodilators and hirudin inhibit the thrombin-stimulated release of endothelin from the intact porcine aorta by two different mechanisms.
C. Boulanger, T.F. Lüscher.
Circ Res. 1991;68:1768-72.

Different interactions of platelets with arterial and venous coronary bypass vessels.
Z. Yang, P. Stulz, L. von Segesser, E. Bauer, M. Turina, T.F. Lüscher.
Lancet. 1991;337:939-43.

Endothelium-dependent vascular regulation of the porcine ophthalmic artery.
K. Yao, M. Tschudi, A.J. Flammer, T.F. Lüscher.
Invest Ophthal Vis Sci. 1991;32:1791-8.

Endothelin-1-induced vasoconstriction in man: reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor.
W. Kiowski, T.F. Lüscher, L. Linder, F.R. Bühler.
Circulation. 1991;83:469-75.

Differential activation of the endothelial L-arginine and cyclooxygenase pathway in the human internal mammary artery and saphenous vein.
Z. Yang, L. von Segesser, E. Bauer, P. Stulz, M. Tschudi, T.F. Lüscher.
Circ Res. 1991;68:52-60.

Aging differentially interferes with the direct and indirect vascular effects of endothelin-1.
Y. Dohi, T.F. Lüscher.
Br J Pharmacol. 1990;100:889-93.

Activation of the endothelial L-arginine pathway in pressurized mesenteric resistance arteries: effect of age and hypertension.
Y. Dohi, M. Thiel, F.R. Bühler, T.F. Lüscher.
Hypertension. 1990;15:170-5.

Importance of endothelium-derived nitric oxide in intramyocardial porcine coronary arteries.
M. Tschudi, V. Richard, F.R. Bühler, T.F. Lüscher.
Am J Physiol. 1990;260:H13-20.

Differential activation of the endothelial L-arginine pathway by bradykinin, serotonin and clonidine in porcine coronary arteries.
V. Richard, M. Tschudi, T.F. Lüscher.
Am J Physiol. 1990;259:H1433-9.

Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries: A new mechanism of vasospasm?
Z. Yang, V. Richard, L. von Segesser, E. Bauer, P. Stulz, M. Turina, T.F. Lüscher.
Circulation. 1990;82:188-95.

Indirect evidence for the release of endothelium-derived relaxing factor in the human forearm circulation: blunted response in essential hypertension.
L. Linder, W. Kiowski, F.R. Bühler, T.F. Lüscher.
Circulation. 1990;81:1762-7.

Interaction between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins.
T.F. Lüscher, Z. Yang, M. Tschudi, L. von Segesser, P. Stulz, C. Boulanger, R. Siebenmann, M. Turina, F.R. Bühler.
Circ Res. 1990;66:1088-94.

Release of endothelin from the porcine aorta: inhibition by endothelium-derived nitric oxide. (Rapid publication)
C. Boulanger, T.F. Lüscher.
J Clin Invest. 1990;85:587-90.

Impaired endothelium-dependent relaxations in hypertensive resistance arteries involve the cyclooxygenase pathway.
D. Diederich, Z. Yang, F.R. Bühler, T.F. Lüscher.
Am J Physiol. 1990;258:H445-51.

Interaction between endothelium-derived nitric oxide and SIN-1 in human and porcine blood vessels.
T.F. Lüscher, V. Richard, Z. Yang.
J Cardiovasc Pharmacol. 1990;14(Suppl. 11):S76-80.

Indomethacin enhances the impaired endothelium-dependent relaxations in small mesenteric arteries of the spontaneously hypertensive rat.
T.F. Lüscher, L.L. Aarhus, P.M. Vanhoutte.
Am J Hypertension. 1990;3:55-8.

Endothelium-derived relaxing factor and protection against contractions induced by histamine and serotonin in the human internal mammary artery and in the saphenous vein.
Z. Yang, D. Diederich, K. Schneider, R. Siebenmann, P. Stulz, L. von Segesser, M. Turina, F.R. Bühler, T.F. Lüscher.
Circulation. 1989;80:1041-8.

Doppler characterization of left ventricular diastolic function in cardiac amyloidosis.
A.L. Klein, L.K. Hatle, D.J. Burstow, J.B. Seward, R.A. Kyle, K.R. Bailey, T.F. Lüscher, M.A. Gertz, J.A. Tajik.
J Amer Coll Cardiol. 1989;13:1017-26.

High potassium diet augments endothelium-dependent relaxations in the Dahl rat.
L. Raij, T.F. Lüscher, P.M. Vanhoutte.
Hypertension. 1988;12:562-7.

Difference between endothelium-dependent relaxations in arterial and in venous coronary bypass grafts.
T.F. Lüscher, D. Diederich, R. Siebenmann, K. Lehmann, P. Stulz, L. von Segesser, Z. Yang, M. Turina, E. Grädel, E. Weber, F.R. Bühler.
N Engl J Med. 1988;319:462-7.

Endothelium-dependent responses in the common carotid and renal artery of normotensive and spontaneously hypertensive rats.
T.F. Lüscher, D. Diederich, P.M. Vanhoutte, E. Weber, F.R. Bühler.
Hypertension. 1988;11:573-8.

Antihypertensive therapy normalizes endothelium-dependent relaxations in salt-induced hypertension of the rat.
T.F. Lüscher, P.M. Vanhoutte, L.Raij.
Hypertension. 1987;9(Suppl. III):S193-7.

Serotonin reduces coronary flow in the isolated heart of the spontaneously hypertensive rat.
T.F. Lüscher, G.M. Rubanyi, L.L. Aarhus, Y. Edoute, P.M. Vanhoutte.
J. Hypertension. 1987;4(Suppl. 5):S148-50.

Autoregulation and vascular reserve in the coronary circulation of the spontaneously hypertensive rat.
Y. Edoute, T.F. Lüscher, G.M. Rubanyi.
J. Hypertension. 1987;4(Suppl. 5):S290-2.

Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats.
T.F. Lüscher, L. Raij, P.M. Vanhoutte.
Hypertension. 1987;9:157-63.

Unilateral hydronephrosis and hypertension: cause or coincidence?
C. Wanner, T.F. Lüscher, P. Schollmeyer, W. Vetter.
Nephron. 1987;45:236-41.

Bioassay of endothelium-derived vasoactive substances in the aorta of normotensive and spontaneously hypertensive rats.
T.F. Lüscher, J.C. Romero, P.M. Vanhoutte.
J Hypertension. 1986;4(Suppl. 6):S81-3.

Endothelium-dependent responses to platelets and serotonin in spontaneously hypertensive rats.
T.F. Lüscher, P.M. Vanhoutte.
Hypertension. 1986;8(Suppl. II):S55-60.

Fibromuscular hyperplasia: extension of the disease and therapeutic outcome.
T.F. Lüscher, H.M. Keller, H.G. Imhof, P. Greminger, U. Kuhlmann, F. Largiadèr, E. Schneider, J. Schneider, W. Vetter.
Nephron. 1986;44(Suppl. 1):S109-114.

Surgery, transluminal dilatation and medial therapy in the management of renovascular hypertension.
P. Greminger, T.F. Lüscher, J. Zuber, U. Kuhlmann, E. Schneider, W. Siegenthaler, F. Largiadèr, W. Vetter.
Nephron. 1986;44(Suppl. 1):S36-9.

Renal venous renin determinations in renovascular hypertension: diagnostic and prognostic value in unilateral renal artery stenosis treated by surgery or percutaneous transluminal angioplasty.
T.F. Lüscher, P. Greminger, W. Siegenthaler, W. Vetter.
Nephron. 1986;44(Suppl. 1):S17-24.

Combined 2-D-Ultrasound-Dopplertechnique: new possibilities for the screening of renovascular hypertension?
R. Jenni, A. Vieli, T.F. Lüscher, E. Schneider, W. Vetter, M. Anliker.
Nephron. 1986;44(Suppl. 1):S2-4.

Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat.
T.F. Lüscher, P.M. Vanhoutte.
Hypertension. 1986;8:344-8.

Long-term experience in percutaneous transluminal dilatation of renal artery stenosis.
U. Kuhlmann, P. Greminger, A. Grüntzig, E. Schneider, G. Pouliadis, T. F. Lüscher, J. Steurer, W. Siegenthaler, W. Vetter.
Am J Med. 1985;79:692-8.

Unilateral parenchymatous kidney disease and hypertension: results of nephrectomy and medical treatment.
C. Wanner, T. F. Lüscher, H. Groth, D. Hauri, H.R. Burger, P. Greminger, U. Kuhlmann, W. Siegenthaler, W. Vetter.
Nephron. 1985;4l:250-7.

A simple and effective method to teach patients about high blood pressure and obesity.
L. Neyses, A. Bärtsch, P. Greminger, T. F. Lüscher, U. Keller, L. Bachmann, W. Siegenthaler, W. Vetter.
J Hypertension. 1985;3(Suppl. l):S27-30.

Clinical evaluation of semiautomatic blood pressure devices for self-recording.
R. Steiner, T. F. Lüscher, H.-J. Börlin, W. Siegenthaler, W. Vetter.
J Hypertension. 1985;3(Suppl. l):S23-5.

Long-term experience with captopril in severe hypertension.
J. Havelka, H.-J. Börlin, A. Studer, P. Greminger, W. Tenschert, T. F. Lüscher, W. Siegenthaler, W. Vetter, P. Walger, H. Vetter.
Brit J Clin Pharmacol. 1982;14:71s-6s.

Prinzidilol (SK&F 92 657) a new vasodilator with betablocking properties in the treatment of essential hypertension.
T. F. Lüscher, J. Havelka, P. Greminger, J. Tuma, M. Täuber, W. Siegenthaler, W. Vetter.
Eur J Clin Pharmacol. 1982;23:411-5.

Acute and chronic effects of the angiotensin converting enzyme inhibitor captopril in severe hypertension.
J. Havelka, H. Vetter, A. Studer, P. Greminger, T. F. Lüscher, S. Wollnik, W. Siegenthaler, W. Vetter.
Am J Cardiol. 1982;49:1467-74.

Twenty-four hours secretory pattern of cortisol in the bull: evidence of episodic secretion and circadin rhythm.
R. Thun, E. Eggenberger, U. Zerobin, T. F. Lüscher, W. Vetter.
Endocrinology. 1981;109:2208-12.